<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">98867</article-id><article-id pub-id-type="doi">10.7554/eLife.98867</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.98867.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>NK cell exhaustion in Wilson’s disease revealed by single-cell RNA sequencing predicts the prognosis of cholecystitis</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Jin</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xing</surname><given-names>Jiayu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Dai</surname><given-names>Chenyu</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jin</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wanying</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Tao</surname><given-names>Qianqian</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Hou</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Ziyi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yang</surname><given-names>Wen</given-names></name><email>woodeasy66@hotmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Feng</surname><given-names>Qiyu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0004-5032-7500</contrib-id><email>qiyufeng@ustc.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Hongyang</given-names></name><email>hywangk@vip.sina.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yu</surname><given-names>Qingsheng</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8074-0329</contrib-id><email>qsy6312@163.com</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04c4dkn09</institution-id><institution>Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China</institution></institution-wrap><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03t1yn780</institution-id><institution>Department of Cadre Cardiology, The First Affiliated Hospital of Anhui University of Chinese Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03t1yn780</institution-id><institution>Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution>Institute of Chinese Medicine Surgery, Anhui Academy of Chinese Medicine</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043sbvg03</institution-id><institution>International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04tavpn47</institution-id><institution>National Center for Liver Cancer, Second Military Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Nair</surname><given-names>Shiny</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Taniguchi</surname><given-names>Tadatsugu</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>University of Tokyo</institution></institution-wrap><country>Japan</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>30</day><month>12</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP98867</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-05-01"><day>01</day><month>05</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-05-05"><day>05</day><month>05</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.05.02.592210"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-07-10"><day>10</day><month>07</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.98867.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-12-05"><day>05</day><month>12</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.98867.2"/></event></pub-history><permissions><copyright-statement>© 2024, Jin, Xing, Dai et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Jin, Xing, Dai et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-98867-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-98867-figures-v1.pdf"/><abstract><p>Metabolic abnormalities associated with liver disease have a significant impact on the risk and prognosis of cholecystitis. However, the underlying mechanism remains to be elucidated. Here, we investigated this issue using Wilson’s disease (WD) as a model, which is a genetic disorder characterized by impaired mitochondrial function and copper metabolism. Our retrospective clinical study found that WD patients have a significantly higher incidence of cholecystitis and a poorer prognosis. The hepatic immune cell landscape using single-cell RNA sequencing showed that the tissue immune microenvironment is altered in WD, mainly a major change in the constitution and function of the innate immune system. Exhaustion of natural killer (NK) cells is the fundamental factor, supported by the upregulated expression of inhibitory receptors and the downregulated expression of cytotoxic molecules, which was verified in clinical samples. Further bioinformatic analysis confirmed a positive correlation between NK cell exhaustion and poor prognosis in cholecystitis and other inflammatory diseases. The study demonstrated dysfunction of liver immune cells triggered by specific metabolic abnormalities in WD, with a focus on the correlation between NK cell exhaustion and poor healing of cholecystitis, providing new insights into the improvement of inflammatory diseases by assessing immune cell function.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>NK cell exhaustion</kwd><kwd>metabolic abnormalities</kwd><kwd>immune cell dysfunction</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>2021KY340</award-id><principal-award-recipient><name><surname>Feng</surname><given-names>Qiyu</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81773112</award-id><principal-award-recipient><name><surname>Feng</surname><given-names>Qiyu</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82073186</award-id><principal-award-recipient><name><surname>Feng</surname><given-names>Qiyu</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005891</institution-id><institution>State Administration of Traditional Chinese Medicine of the People's Republic of China</institution></institution-wrap></funding-source><award-id>Teaching Letter [2021] No. 270</award-id><principal-award-recipient><name><surname>Yu</surname><given-names>Qingsheng</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Metabolic abnormalities in hepatocytes cause the alteration of transcriptional profile and function of immune cells in the tissue microenvironment.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Cholecystitis refers to a group of inflammatory diseases with different etiologies and clinical courses (<xref ref-type="bibr" rid="bib30">Elwood, 2008</xref>). While the corresponding pathological mechanisms of cholecystitis are complicated, systemic inflammation is widely recognized as a primary catalyst of cholecystitis pathology (<xref ref-type="bibr" rid="bib42">Huffman and Schenker, 2010</xref>; <xref ref-type="bibr" rid="bib57">Markaki et al., 2021</xref>; <xref ref-type="bibr" rid="bib49">Laurila et al., 2005</xref>; <xref ref-type="bibr" rid="bib33">Fu et al., 2022</xref>; <xref ref-type="bibr" rid="bib2">Abu-Sbeih et al., 2019</xref>). Cholecystectomy is typically the preferred treatment option for patients with severe cholecystitis and gallstones, whereas medication is prescribed for those with mildly symptomatic cholecystitis or calculous cholecystitis. However, a substantial percentage of patients face the possibility of complications or recurrence (<xref ref-type="bibr" rid="bib54">Loozen et al., 2017</xref>; <xref ref-type="bibr" rid="bib85">van Dijk et al., 2016</xref>). Compelling evidence supports that the proportion, gene expression profile, and functional status of immune cells hold significant prognostic value (<xref ref-type="bibr" rid="bib14">Buonacera et al., 2022</xref>; <xref ref-type="bibr" rid="bib59">McKinney et al., 2010</xref>; <xref ref-type="bibr" rid="bib60">McKinney et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Sun et al., 2021</xref>; <xref ref-type="bibr" rid="bib32">Fridman et al., 2017</xref>; <xref ref-type="bibr" rid="bib93">Wouters and Nelson, 2018</xref>). Therefore, it is critical to comprehensively comprehend the immune cell dysfunction linked with cholecystitis, its corresponding altered characteristics, and their prognostic implications.</p><p>Natural killer (NK) cells are the major innate lymphocyte subset and are found in most organs (<xref ref-type="bibr" rid="bib1">Abel et al., 2018</xref>; <xref ref-type="bibr" rid="bib20">Crinier et al., 2020</xref>). They produce lytic granules that eliminate infected or cancerous cells, coordinate the inflammation process, form immunological memory, and modulate antigen-presenting cell function in inflammatory diseases (<xref ref-type="bibr" rid="bib40">Highton et al., 2021</xref>; <xref ref-type="bibr" rid="bib64">Parisi et al., 2017</xref>; <xref ref-type="bibr" rid="bib28">Earls and Lee, 2020</xref>). In the context of tumors and chronic infections, NK cells exhibit an exhausted phenotype, termed NK cell exhaustion, which is characterized by downregulated expression of activating receptors (e.g. NKG2D, FCGR3A), upregulated expression of inhibitory receptors (e.g. KLRC1, PD-1, TIGIT, Tim-3), decreased production of effector cytokines (e.g. IFNγ, GZMB), and impaired cytolytic activity (<xref ref-type="bibr" rid="bib12">Bi and Tian, 2017</xref>; <xref ref-type="bibr" rid="bib102">Zhang et al., 2018</xref>). Recently, blockade of KLRC1 and TIGIT has been shown to reverse NK cell exhaustion and enhance the therapeutic effects of anti-tumor and anti-infective immunotherapies (<xref ref-type="bibr" rid="bib102">Zhang et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">Liu et al., 2023</xref>; <xref ref-type="bibr" rid="bib104">Zhang et al., 2019b</xref>). In addition, NK cell exhaustion has been reported to predict poor prognosis in hepatocellular carcinoma and acute myeloid leukemia; however, the correlation of NK cell exhaustion with prognosis in cholecystitis and other inflammatory diseases remains largely unexplored (<xref ref-type="bibr" rid="bib80">Sun et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">Liu et al., 2022</xref>; <xref ref-type="bibr" rid="bib79">Sun et al., 2017</xref>).</p><p>The liver plays a critical role in immune defense. It contains a substantial population of diverse immune cells, particularly NK cells (<xref ref-type="bibr" rid="bib21">Crispe, 2009</xref>; <xref ref-type="bibr" rid="bib48">Kubes and Jenne, 2018</xref>; <xref ref-type="bibr" rid="bib70">Racanelli and Rehermann, 2006</xref>). The liver modulates these cells to mount immune responses upon encountering specific inflammatory triggers (<xref ref-type="bibr" rid="bib48">Kubes and Jenne, 2018</xref>; <xref ref-type="bibr" rid="bib37">Hardy et al., 2016</xref>). Furthermore, liver pathologies affect mesenchymal immune cell function and influence systemic inflammatory responses, impacting the development and outcome of inflammation-associated diseases such as cholecystitis (<xref ref-type="bibr" rid="bib7">Armstrong et al., 2014</xref>; <xref ref-type="bibr" rid="bib58">Matyas et al., 2021</xref>; <xref ref-type="bibr" rid="bib47">Knab et al., 2014</xref>). Wilson’s disease (WD) is a rare genetic disorder caused by mutations in the gene encoding the transmembrane copper-transporting P-type ATPase protein (<xref ref-type="bibr" rid="bib9">Bandmann et al., 2015</xref>). It leads to deficits in mitochondrial structure and function, as well as specific alterations in liver metabolism, resulting in a variety of liver diseases. Additionally, WD is commonly associated with inflammatory conditions in the clinic (<xref ref-type="bibr" rid="bib43">Huster et al., 2006</xref>; <xref ref-type="bibr" rid="bib61">Medici et al., 2013</xref>; <xref ref-type="bibr" rid="bib44">Huster, 2014</xref>; <xref ref-type="bibr" rid="bib3">Aggarwal and Bhatt, 2020</xref>). Thus, WD, with its unique etiology, serves as an excellent model for exploring the regulation of immune cell function by hepatic metabolic abnormalities.</p><p>In this retrospective clinical study of over 600 WD patients, it was found that they had a significantly higher cholecystitis incidence than the general population. This, in turn, is associated with a poor prognosis for cholecystitis in these patients. A thorough examination of the immune cell landscape in the hepatic mesenchymal stromal microenvironment of WD patients was performed using single-cell RNA sequencing (scRNA-seq). Specifically, there were significant changes in the composition and function of the innate immune system, including an increase of mononuclear phagocytes (MPs) and NK cells, as well as enhanced pro-inflammatory characteristics. Additionally, there was an enhancement in the biological processes of antigen presentation, activation of immune response, and activation of lymphocytes. One key event among these changes was the exhaustion of NK cells, as demonstrated by an increase in the expression of inhibitory receptors KLRC1 and TIGIT and a decrease in the expression of cytotoxic molecules. Multiplex immunohistochemistry (mIHC) and flow cytometry techniques confirmed the exhaustion of NK cells in both clinical liver tissue and peripheral blood samples. Finally, our bioinformatics analysis has confirmed a positive correlation between NK cell exhaustion and poor prognosis in cholecystitis and other inflammatory diseases. Our study has demonstrated abnormal liver mesenchymal immune cell function triggered by specific metabolic dysfunction in WD, focusing on NK cell exhaustion and its correlation with poor healing of cholecystitis. These findings provide foundation for further studies of effect of hepatocytes metabolic changes on immune cell function and insights into improvement of inflammatory diseases by assessing immune cell function.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>WD causes poor prognosis of cholecystitis</title><p>WD is a genetic disorder resulting from mutations in the <italic>ATP7B</italic> gene, exhibiting significant genetic heterogeneity with over 600 mutations or polymorphisms (<xref ref-type="bibr" rid="bib18">Cheng et al., 2017</xref>). Through sequencing DNA samples from 20 patients with WD, we found that c. 2333G&gt;T (p. R778L) accounted for the majority (65%) of the three most common mutations in Chinese, while c. 2804C&gt;T (p. T935M) and c. 2975C&gt;T (p. P992L) were not detected (<xref ref-type="fig" rid="fig1">Figure 1a</xref>; <xref ref-type="bibr" rid="bib98">Yang et al., 2021</xref>). In hepatocytes, ATP7B deficiency in the trans-Golgi network (TGN) leads to abnormalities in mitochondrial function and copper metabolism, and ultimately to a wide range of liver diseases (<xref ref-type="fig" rid="fig1">Figure 1b</xref>; <xref ref-type="bibr" rid="bib22">Członkowska et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Roberts et al., 2008</xref>; <xref ref-type="bibr" rid="bib109">Zischka and Lichtmannegger, 2014</xref>; <xref ref-type="bibr" rid="bib62">Muchenditsi et al., 2021</xref>). Typical clinical manifestations are liver fibrosis and Kayser-Fleischer ring in the cornea that caused by Cu accumulation in the cornea (<xref ref-type="fig" rid="fig1">Figure 1c and d</xref>; <xref ref-type="bibr" rid="bib22">Członkowska et al., 2018</xref>). Additionally, a lower total bilirubin and metabolic symptoms of WD patients, a lower risk of hyperglycemia (Cohort 1 and Cohort 2), are observed (<xref ref-type="fig" rid="fig1">Figure 1e</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>). Mitochondrial stress and glycolysis assays revealed that knockout of the <italic>ATP7B</italic> (ATP7B-KO) in human hepatocyte cell lines WRL 68 significantly impaired the basal oxygen consumption rate (OCR) and capacity of ATP production, while the extracellular acidification rate (ECAR) of glycolysis and glycolysis capacity remained unchanged (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b and c</xref>). These results demonstrate that WD is a disease characterized by abnormal hepatocyte metabolism.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Clinical manifestation of Wilson’s disease (WD) patients and WD causes poor prognosis of cholecystitis.</title><p>(<bold>a</bold>) DNA sequencing result of 20 WD patients was summarized in the graph. (<bold>b</bold>) The schematic diagram illustrates copper transport disturbances caused by ATP7B mutations, along with structural and functional impairments in mitochondria. Created with <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/i79f731">BioRender.com</ext-link>. (<bold>c</bold>) Masson-trichrome staining of liver tissues of patients with WD and control. (<bold>d</bold>) The picture of Kayser-Fleischer (KF) ring in the cornea of a patient with WD, captured during clinical examination. (<bold>e</bold>) The table of clinical statistics of patients in three cohorts. Data are mean ± SD. Unpaired two-tailed t-test and chi-square test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title><italic>ATP7B</italic> mutation causes metabolic abnormalities.</title><p>(<bold>a</bold>) The table of clinical characteristics of patients in three cohorts at baseline. Data are mean ± SD. (<bold>b</bold>) Mitochondrial stress (oxygen consumption rate [OCR]) measured in <italic>ATP7B</italic>-KO (n=3) and NC (n=3) WRL 68 cell lines. Bar charts showing the statistical results of basal respiration and ATP production. Unpaired two-tailed t-test. (<bold>c</bold>) Glycolysis stress (extracellular acidification rate [ECAR]) measured in <italic>ATP7B</italic>-KO (n=3) and NC (n=3) WRL 68 cell lines. Bar charts showing the statistical results of glycolysis, and glycolysis capacity. Unpaired two-tailed t-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Interestingly, chronic cholecystitis emerged as the most common complication, with a notably higher incidence in WD patients (49.51%) compared to HBV patients (9.46%) in Cohort 2 (<xref ref-type="fig" rid="fig1">Figure 1e</xref>). Despite the comparable incidence of gallbladder in the two groups and the significantly reduced plasma concentration of total bilirubin in WD patients (Cohort 1 and Cohort 2), this finding holds (<xref ref-type="fig" rid="fig1">Figure 1e</xref>). Moreover, in cholecystitis patients, the proportion of cases with abnormal index was significantly higher when combined with WD, which included white blood cell (WBC), neutrophil (NEU), and lymphocyte (LYM) counts (Cohort 3, <xref ref-type="fig" rid="fig1">Figure 1e</xref>). Overall, these findings suggest that cholecystitis outcomes are negatively affected by WD.</p></sec><sec id="s2-2"><title>Single-cell profiling of non-parenchymal cells in the liver of WD patients</title><p>The hepatic mesenchymal cells from three WD patients and three liver hemangioma patients were analyzed using the 10x Genomics platform for scRNA-seq (<xref ref-type="fig" rid="fig2">Figure 2a</xref>) to better understand the complicated immune cell abnormalities in WD patients. 57,384 high-quality single transcriptomes were generated, with 30,068 cells in the group of WD patients (CASE) and 27,316 in the group of liver hemangioma patients (CON). We validated 26 principal components via PCA and substantiated the grouping through UMAP dimensionality reduction cluster graph (<xref ref-type="fig" rid="fig2">Figure 2b and c</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a</xref>). We then utilized individual cell expression profiles and reference to cell marker gene expression to implement an automated annotation method, which was further complemented by manual review and fine-tuning. This initial annotation process resulted in the classification and display of 12 significant cell clusters. The UMAP algorithm was used to segregate and display the clusters. The study identified various cell types, including hepatocytes (<xref ref-type="bibr" rid="bib38">He et al., 2020</xref>), cholangiocytes (<xref ref-type="bibr" rid="bib38">He et al., 2020</xref>), endothelial cells (ECs) (<xref ref-type="bibr" rid="bib50">Li et al., 2021</xref>; <xref ref-type="bibr" rid="bib74">Sathe et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Wang et al., 2020d</xref>), hepatic stellate cells (HepSCs) (<xref ref-type="bibr" rid="bib11">Bhattacharjee et al., 2021</xref>), proliferating cells (<xref ref-type="bibr" rid="bib74">Sathe et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Dumas et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Durante et al., 2020</xref>), B cells (<xref ref-type="bibr" rid="bib34">Gong et al., 2021</xref>; <xref ref-type="bibr" rid="bib89">Wang et al., 2020c</xref>), plasma cells (<xref ref-type="bibr" rid="bib27">Durante et al., 2020</xref>; <xref ref-type="bibr" rid="bib34">Gong et al., 2021</xref>), T and NK cells (<xref ref-type="bibr" rid="bib34">Gong et al., 2021</xref>; <xref ref-type="bibr" rid="bib100">Zeng et al., 2019</xref>; <xref ref-type="bibr" rid="bib107">Zhang et al., 2023</xref>), neutrophils (<xref ref-type="bibr" rid="bib95">Wu et al., 2021</xref>), mast cells (<xref ref-type="bibr" rid="bib74">Sathe et al., 2020</xref>; <xref ref-type="bibr" rid="bib100">Zeng et al., 2019</xref>; <xref ref-type="bibr" rid="bib95">Wu et al., 2021</xref>), MPs (<xref ref-type="bibr" rid="bib71">Ramachandran et al., 2019</xref>), and plasmacytoid dendritic cells (pDCs) (<xref ref-type="bibr" rid="bib74">Sathe et al., 2020</xref>; <xref ref-type="bibr" rid="bib66">Pombo Antunes et al., 2021</xref>; <xref ref-type="fig" rid="fig2">Figure 2d, e</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1b, c</xref>). <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1d</xref> exhibited the top 10 differently expressed genes (DEGs) for each cell type.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Single-cell profiling of non-parenchymal cells in the liver of Wilson’s disease (WD) patients.</title><p>(<bold>a</bold>) The workflow of single-cell RNA sequencing (scRNA-seq). Created with <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/i79f731">BioRender.com</ext-link>. (<bold>b</bold>) UMAP visualization of 26 principal components of all the single cells. (<bold>c</bold>) UMAP visualization of 26 principal components by samples. (<bold>d</bold>) UMAP visualization of 12 main cell types. (<bold>e</bold>) The dot plot showing the expression of top 3 marker genes in 12 main cell types. (<bold>f</bold>) The bar chart showing the proportion of 12 main cell types in each sample.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>The proportion and differently expressed genes (DEGs) of each main cell type.</title><p>(<bold>a</bold>) UMAP visualization of principal components by six samples. (<bold>b</bold>) UMAP visualization of 12 main cell types by six samples, corresponding to <xref ref-type="fig" rid="fig2">Figure 2d</xref>. (<bold>c</bold>) The table displaying cell marker genes for annotation of main cell types. (<bold>d</bold>) The heatmap showing the top 10 DEGs for each cell type. (<bold>e</bold>) The bar chart showing the average percentage of different cell types in CASE (n=3) and CON (n=3). Data are mean ± SD.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Based on the initial annotation, there were notable variations in the quantities and ratios of different cell types between CASE and CON. Our study observed that T and NK lineages were the primary immune cell population among all the examined samples, accounting for 56.54% in CASE and 73.55% in CON, followed by MPs which constituted 17.33% in CASE and 9.97% in CON (<xref ref-type="fig" rid="fig2">Figure 2f</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1e</xref>, and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). The significant increase in the proportion of MPs and decrease in T and NK cells suggest that MPs likely dominate the immune microenvironment remodeling in WD patients, while lymphocytes play a minor role. B cell proportions (4.53% in CASE and 2.27% in CON), plasma cell proportions (2.36% in CASE and 0.42% in CON), and pDC proportions (0.42% in CASE and 0.16% in CON) were elevated, while neutrophil proportions (3.53% in CASE and 6.45% in CON) declined. The proportion of remaining cells is shown in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>.</p></sec><sec id="s2-3"><title>An overview of the immune microenvironment in WD patients</title><p>To demonstrate dissimilarities in the composition of the immune microenvironment between the two groups of individuals in a more detailed manner, a secondary subtype clustering and annotation process was applied to MPs and T and NK cells (<xref ref-type="fig" rid="fig3">Figure 3a, b</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a, b</xref>). MPs are myeloid immune cells that serve phagocytic and antigen-presenting functions. These cells, which include monocytes, macrophages, and dendritic cells, play an essential role in determining the nature of the immune response (<xref ref-type="bibr" rid="bib77">Strauss et al., 2015</xref>). A total of 6962 MPs were identified (4439 in CASE and 2523 in CON), and they were subdivided into seven clusters through annotation (<xref ref-type="fig" rid="fig3">Figure 3a</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a</xref>, and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). Cell marker genes for annotating cell subtypes were depicted in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1c and d</xref>, and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1e</xref> demonstrated the top 10 DEGs between the two groups (<xref ref-type="bibr" rid="bib81">Sun et al., 2021</xref>; <xref ref-type="bibr" rid="bib74">Sathe et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Wang et al., 2020d</xref>; <xref ref-type="bibr" rid="bib26">Dumas et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Durante et al., 2020</xref>; <xref ref-type="bibr" rid="bib100">Zeng et al., 2019</xref>; <xref ref-type="bibr" rid="bib107">Zhang et al., 2023</xref>; <xref ref-type="bibr" rid="bib95">Wu et al., 2021</xref>; <xref ref-type="bibr" rid="bib71">Ramachandran et al., 2019</xref>; <xref ref-type="bibr" rid="bib66">Pombo Antunes et al., 2021</xref>; <xref ref-type="bibr" rid="bib76">Singh et al., 2019</xref>; <xref ref-type="bibr" rid="bib36">Halbritter et al., 2019</xref>; <xref ref-type="bibr" rid="bib10">Bassez et al., 2021</xref>; <xref ref-type="bibr" rid="bib67">Popescu et al., 2019</xref>; <xref ref-type="bibr" rid="bib16">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="bib88">Wang et al., 2020b</xref>). The DEGs were related to various cell types, including proliferating cells, macrophages, monocytes, mature dendritic cells (MatureDCs), conventional type 1 dendritic cells (cDC1), conventional type 2 dendritic cells (cDC2), and Kupffer cells (KCs). In CASE, there was a significant increase in both macrophages (25.03% in CASE versus 14.33% in CON) and KCs, the resident macrophages in the liver (26.03% in CASE versus 22.96% in CON), suggesting their involvement in promoting hepatic inflammation in metabolic liver disease (<xref ref-type="fig" rid="fig3">Figure 3a</xref>; <xref ref-type="bibr" rid="bib25">Dixon et al., 2013</xref>). By contrast, the percentages of monocytes (35.45% in CASE and 41.78% in CON), cDC1 (2.14% in CASE and 5.99% in CON), and cDC2 (10.39% in CASE and 14.13% in CON) were decreased in CASE (<xref ref-type="fig" rid="fig3">Figure 3a</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>An overview of the immune microenvironment in Wilson’s disease (WD) patients.</title><p>(<bold>a</bold>) UMAP visualization of mononuclear phagocytes (MPs) colored and labeled by cell subtypes (left). The bar chart showing the average percentage of different subtypes in CASE (n=3) and CON (n=3) (right). Data are mean ± SD. (<bold>b</bold>) UMAP visualization of T and NK cells colored and labeled by cell subtypes (left). The bar chart showing the average percentage of different subtypes in CASE (n=3) and CON (n=3) (right). Data are mean ± SD. (<bold>c</bold>) The heatmap showing the top 20 differently expressed genes (DEGs) for all immune cells. (<bold>d</bold>) The dot plot showing Gene Ontology (GO) enrichment on DEGs of all immune cells between CASE and CON. BP, biological processes; CC, cellular components; MF, molecular function. (<bold>e</bold>) The scatter showing the incoming and outgoing interaction strength of all cell subtypes in CASE and CON.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>The gene expression characteristics of each cell subtype.</title><p>(<bold>a</bold>) UMAP visualization of cell subtypes in mononuclear phagocytes (MPs) by six samples, corresponding to <xref ref-type="fig" rid="fig3">Figure 3a</xref>. (<bold>b</bold>) UMAP visualization of cell subtypes in T and natural killer (NK) cells by six samples, corresponding to <xref ref-type="fig" rid="fig3">Figure 3b</xref>. (<bold>c</bold>) The table displaying cell marker genes for annotation of cell subtypes. (<bold>d</bold>) The dot plot showing the expression of top 3 marker genes in each cell subtypes. (<bold>e</bold>) The heatmap showing the top 10 differently expressed genes (DEGs) for each cell subtypes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Seventeen clusters were obtained through reclustering for the largest population of T and NK cells, totaling 34,339 cells (15,403 cells in CASE and 18,936 in CON) (<xref ref-type="bibr" rid="bib34">Gong et al., 2021</xref>; <xref ref-type="bibr" rid="bib95">Wu et al., 2021</xref>; <xref ref-type="bibr" rid="bib15">Cella et al., 2019</xref>; <xref ref-type="bibr" rid="bib29">Elmentaite et al., 2021</xref>; <xref ref-type="bibr" rid="bib51">Liu et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Wang et al., 2020a</xref>; <xref ref-type="bibr" rid="bib83">Tirosh et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Jaeger et al., 2021</xref>; <xref ref-type="bibr" rid="bib24">Depuydt et al., 2020</xref>; <xref ref-type="bibr" rid="bib4">Andor et al., 2019</xref>; <xref ref-type="bibr" rid="bib39">Heming et al., 2021</xref>; <xref ref-type="bibr" rid="bib96">Xin et al., 2022</xref>; <xref ref-type="bibr" rid="bib108">Zhao et al., 2020</xref>; <xref ref-type="bibr" rid="bib92">Williams et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Madissoon et al., 2019</xref>; <xref ref-type="bibr" rid="bib105">Zhang et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Fernandez et al., 2019</xref>; <xref ref-type="bibr" rid="bib55">Luoma et al., 2020</xref>). The clusters included ILC3_IL1R1, NKT_GNLY, NKT_IFNG, NKT_KLRG1, NK_FCER1G, NK_KLRC1, NKT_XCL2, NK_FCGR3A, CD4NaiveT_CCR7, CD4Tmem_CD40LG, CD4Treg_CTLA4, CD8MAIT_KLRB1, CD8MAIT_SLC4A10, CD8Teff_GZMH, CD8Teff_GZMK, CD8Teff_ISG15, and CD8Teff_MT1X (<xref ref-type="fig" rid="fig3">Figure 3b</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1b</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). The proportion of NK cells (40.97% and 17.07% in CASE and CON, respectively) and CD4Treg (0.92% and 0.31% in CASE and CON, respectively) was significantly increased in CASE. On the other hand, a decrease of NKT cells (28.72% in CASE and 35.26% in CON), CD8MAIT (7.76% in CASE and 22.14% in CON), and CD8Teff (14.95% in CASE and 17.88% in CON) was observed in CASE. CD4 regulatory T cells are thought to inhibit T cell activation in autoimmune and virus-related liver diseases, indicating a correlation between elevated CD4 regulatory T cells and reduced CD8 T cells in WD patients (<xref ref-type="bibr" rid="bib101">Zhang et al., 2016</xref>). The distribution of other types of cells between the two groups is shown in <xref ref-type="fig" rid="fig3">Figure 3b</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>.</p><p>To systematically evaluate the key functional alteration, we analyzed the top 20 DEGs in all immune cell populations. We found that the expression of genes encoding complement C1q (<italic>C1QA</italic>, <italic>C1QB</italic>, and <italic>C1QC</italic>) and <italic>HLA-DRA</italic> was significantly upregulated in CASE. Conversely, the expression of genes encoding heat shock protein (<italic>HSPA1A</italic>, <italic>HSPA1B</italic>, <italic>HSPM1</italic>, <italic>HSPA6</italic>, <italic>HSP90AB1</italic>, <italic>HSPE1</italic>, and <italic>HSPD1</italic>) was markedly downregulated in CASE (<xref ref-type="fig" rid="fig3">Figure 3c</xref>). The Gene Ontology (GO) analysis results demonstrate that WD enhances the abilities of antigen-presenting cells to activate immune response and related lymphocytes, through upregulating antigen processing and presentation, activation of immune response, and positive regulation of lymphocyte activation. However, heat shock proteins delivering antigens may be responsible for the downregulation of lymphocytes differentiation and T cell activation (<xref ref-type="bibr" rid="bib75">Shevtsov and Multhoff, 2016</xref>). Next, we analyzed the cellular communication network using CellChat. The primary signal senders and receivers were shown, with their respective strength. Our findings reveal that CD8Teff, KCs, NKT, CD8MAIT, monocytes, cDC2, and macrophage were the primary participants in intercellular communication, with the high value in both incoming and outgoing interaction strength (<xref ref-type="fig" rid="fig3">Figure 3e</xref>). Furthermore, the incoming interaction strength of CD8Teff and NK cells was higher in CASE, suggesting the regulation of biological process by extracellular signals, while neutrophils and monocytes exhibited the lower interaction strength in both outgoing and incoming (<xref ref-type="fig" rid="fig3">Figure 3e</xref>). Collectively, these results demonstrate changes in the composition and effects of innate immunity in the liver of WD patients.</p></sec><sec id="s2-4"><title>The dysfunction of main immune cells in WD patients</title><p>To obtain a detail analysis of function comparison in immune cells between two groups, we scored and evaluated the core functional signature of major cell types. We further clustered macrophages, which accounted for 14.33% of the MPs in CON and increased to 25.03% in CASE, resulting in the identification of four distinct subtypes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a</xref>). Interestingly, these four subtypes in the WD patients exhibited distinct gene expression profiles. Macrophages_3 in CASE displayed elevated expression levels of S100A family genes (<italic>S100A8</italic>, <italic>S100A9</italic>, <italic>S100A12</italic>, <italic>S100A6</italic>, <italic>VCAN</italic>, <italic>FCN1</italic>, and <italic>S100A4</italic>), indicating a potential contribution to MDSC-like macrophages. In contrast, Macrophages_4 in CASE were characterized by upregulation of lipid metabolism genes (<italic>FABP5</italic>, <italic>APOC1</italic>, <italic>CTSD</italic>, and <italic>PLA2G7</italic>) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1b</xref>; <xref ref-type="bibr" rid="bib103">Zhang et al., 2019a</xref>; <xref ref-type="bibr" rid="bib91">Wang et al., 2022</xref>). By scoring various gene signatures, we compared the M1 polarization, M2 polarization, pro-inflammatory signature, and interferon response signature of four subtypes within two groups (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). These four subtypes displayed consistently overlapped M1/M2 signatures. Significantly, the Macrophages_3 subtype exhibited a more pronounced pro-inflammatory signal in CASE, while the other subtypes showed a slight decrease. In addition, the interferon response signature showed slight elevation in four subtypes in CASE. Kupffer cells, which are liver-resident macrophages with unique functions in maintaining homeostasis, represent the most abundant population of tissue-resident macrophages in the human body (<xref ref-type="bibr" rid="bib25">Dixon et al., 2013</xref>). KCs were also further clustered and three subtypes were obtained (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1c</xref>). Significant differential expression of genes related to the inflammatory response, including <italic>IL1B</italic>, <italic>CXCL2</italic>, <italic>CCL3C1</italic>, <italic>CXCL8</italic>, and <italic>CCL2</italic>, were identified between the two groups (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1d</xref>). Similarly, KCs subtypes in two groups also showed overlapping M1/M2 signatures, but all subtypes in CASE showed varying degrees of increase in pro-inflammatory and interferon-responsive signatures (<xref ref-type="fig" rid="fig4">Figure 4b</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The dysfunction of main immune cells in Wilson’s disease (WD) patients.</title><p>(<bold>a</bold>) The violin plots displaying M1 polarization, M2 polarization, pro-inflammatory signature, and interferon responsed signature of the four subtypes of macrophages between the two groups by gene scoring. (<bold>b</bold>) The violin plots displaying M1 polarization, M2 polarization, pro-inflammatory signature, and interferon responsed signature of the three subtypes of Kupffer cells between the two groups by gene scoring. (<bold>c</bold>) The violin plots displaying maturation, phagocytosis, chemotaxis, chemokine activity, and Type I interferon signaling pathway scores of neutrophils between the two groups by gene scoring. (<bold>d</bold>) The heatmap showing the relative expression level of genes of the three subtypes of DC cells between the two groups. The color represents the relative expression level. (<bold>e</bold>) The heatmap showing the relative expression level of genes of B cells and plasma cells between the two group. The color represents the relative expression level. (<bold>f</bold>) The dot plot showing biological process of Gene Ontology (GO) enrichment on differentially expressed genes (DEGs) in monocytes between the two group. Upper, upregulation; down, downregulation. (<bold>g</bold>) The violin plots displaying cytotoxicity and exhaustion scores of the six cell subtypes of CD8 T cells between the two groups by gene scoring. (<bold>h</bold>) The violin plots displaying Treg scores of the three cell subtypes of CD4 T cells between the two groups by gene scoring.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>The difference in percentage and gene expression of each cell subtype between CASE and CON.</title><p>(<bold>a</bold>) UMAP visualization of the four further clustered subtypes of macrophages (left). The bar chart showing the percentage of each subtype across different samples (right). (<bold>b</bold>) The heatmap showing the top 10 differently expressed genes (DEGs) for each cell subtype of macrophages. (<bold>c</bold>) UMAP visualization of the three further clustered subtypes of Kupffer cells (KCs) (left). The bar chart showing the percentage of each subtype across different samples (right). (<bold>d</bold>) The heatmap showing the top 10 DEGs for each cell subtype of KCs. (<bold>e</bold>) The heatmap showing the top 20 DEGs for B cells. (<bold>f</bold>) UMAP visualization of the two further clustered subtypes of monocytes (left). The bar chart showing the percentage of each subtype across different samples (right). (<bold>g</bold>) The dot plot showing the expression of top 3 marker genes in each cell subtypes (left). The violin plot showing the expression of top 3 DEGs for two cell subtypes (right). (<bold>h</bold>) The dot plot showing the upregulated biological process of Gene Ontology (GO) enrichment on DEGs in each cell subtype between CASE and CON.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Neutrophils, the most abundant leukocytes in human blood, respond to inflammatory stimuli by migrating to the site of inflammation. Its immunological functions, such as phagocytosis, reactive oxygen species generation, degranulation, and production of cytokines and chemokines, play a crucial role in the resolution of inflammation and tissue repair (<xref ref-type="bibr" rid="bib82">Tang et al., 2021</xref>; <xref ref-type="bibr" rid="bib19">Cho and Szabo, 2021</xref>). In CASE, a lower percentage of neutrophils (3.53% in CASE and 6.45% in CON) was observed, and the functional characteristics were subsequently evaluated. The results showed that the maturation, chemotaxis, phagocytosis, and chemokine activity scores were decreased in CASE, while the activation of the type I interferon signaling pathway was enhanced (<xref ref-type="fig" rid="fig4">Figure 4c</xref>).</p><p>Since the biological process of antigen processing and presentation was upregulated, we calculated the relative expression intensity of genes encoding MHC molecules and complement molecules in cDC1, cDC2, and mature DCs (<xref ref-type="fig" rid="fig4">Figure 4d</xref>). Notably, genes encoding MHC class I molecules (<italic>HLA-A</italic>, <italic>-B</italic>, <italic>-C</italic>, <italic>-E</italic>, and <italic>-F</italic>) were significantly upregulated in the mature DCs in CASE, while genes encoding MHC class II molecules (<italic>HLA-DQA1</italic>, <italic>-DQA2</italic>, <italic>-DQB1</italic>, <italic>-DQB2</italic>, <italic>-DPA1</italic>, <italic>-DPB1</italic>, <italic>-DRA</italic>, <italic>-DRB1</italic>, and <italic>-DRB5</italic>) were all downregulated in the mature DCs. Besides, genes encoding MHC molecules were not the top significant DEGs in B cells, while the immunoglobulin genes (<italic>IGHD</italic> and <italic>IGHM</italic>) and the naïve B cell marker <italic>TCL1A</italic> were significantly upregulated in CASE (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1e</xref>). Then the immunoglobulin genes (<italic>IGHA1</italic>, <italic>IGHA2</italic>, <italic>IGHG1</italic>, <italic>IGHG2</italic>, <italic>IGHG3</italic>, <italic>IGHG4</italic>, <italic>IGHD</italic>, and <italic>IGHM</italic>) expression was compared in B cells and plasma cells (<xref ref-type="fig" rid="fig4">Figure 4e</xref>). <italic>IGHA1</italic>, <italic>IGHA2</italic>, <italic>IGHG1</italic>, <italic>IGHG2</italic>, <italic>IGHG3</italic>, and <italic>IGHG4</italic> expression were unchanged in B cells between the two group and all of examined genes were downregulated except <italic>IGHG3</italic> in plasma cells in CASE.</p><p>Monocytes accounted for the highest proportion (35.45% in CASE and 41.78% in CON), and most of them were CD14<sup>+</sup> classical monocytes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1f</xref>). Compared to CON, <italic>S100A8</italic>, <italic>S100A9</italic>, and <italic>S100A12</italic> were the top 3 upregulated genes in classical monocytes of CASE (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1g</xref>). <italic>S100A8</italic> and <italic>S100A9</italic> are confirmed to play vital roles in modulating the inflammatory responses by recruiting leukocytes and inducing cytokine secretion during inflammation, and as an alarmin, their elevation indicates inflammation in the local environment (<xref ref-type="bibr" rid="bib86">Wang et al., 2018</xref>; <xref ref-type="bibr" rid="bib17">Chen et al., 2023</xref>). GO analysis of DEGs in monocytes showed a decrease in biological processes involving cytokine production, response to lipopolysaccharide and bacteria, as well as lymphocyte activation (<xref ref-type="fig" rid="fig4">Figure 4f</xref>).</p><p>For T cells, we performed GO analysis on DEGs in CD8 T cells between two groups. Notably, the biological processes linked to energy and lipid metabolism were upregulated in several subtypes, including CD4Tmem_CD40LG, CD4Treg_CTLA4, CD8MAIT_KLRB1, CD8MAIT_SLC4A10, CD8Teff_GZMH, and CD8Teff_GZMK. In addition, biological processes associated with response to copper ion were upregulated in the CD8Teff_MT1X subtype (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1h</xref>). Meanwhile, T cell subtypes showed comparable cytotoxicity scores, and there were slight changes between two groups (<xref ref-type="fig" rid="fig4">Figure 4g</xref>). However, CD8 T cells in CASE exhibited lower levels of exhaustion, except for CD8Teff_GZMH and CD8Teff_ISG15 (<xref ref-type="fig" rid="fig4">Figure 4g</xref>). It was also discovered that while the proportion of CD4Treg_CTAL4 was increased in CASE, the Treg signature was slightly lower (<xref ref-type="fig" rid="fig4">Figure 4h</xref>). Therefore, these results suggest that WD patients exhibit variations in immune cell function and certain biological processes.</p></sec><sec id="s2-5"><title>NK cell exhaustion in WD patients</title><p>The Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of DEGs in NK cells between CASE and CON revealed downregulation of the NK cell-mediated cytotoxicity, along with the NF-kappa B signaling pathway and chemokine signaling pathway, in CASE (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1a</xref>). Interestingly, GO analysis showed upregulated biological processes of oxidative phosphorylation and ATP metabolic process, implying the altered metabolic program in NK cells and immune microenvironment (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1b</xref>). Since the primary effect of NK cells is cytotoxicity on target cells, we compared the gene expression levels of activating receptors, inhibitory receptors, and effector molecules between two groups. The results showed significantly upregulated expression in <italic>KLRC1</italic> and <italic>TIGIT</italic>, and significantly downregulated expression in <italic>FCGR3A</italic>, <italic>TNF</italic>, <italic>IFNG</italic>, <italic>GZMB</italic>, <italic>GNLY</italic>, and <italic>CCL4</italic> (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). NK cells were clustered into three NK subtypes, NK_FCER1G, NK_KLRC1, and NK_FCGR3A, by gene expression profile. Analysis of the expression of these genes in three NK subtypes yielded similar results, except for increased expression of <italic>GZMB</italic> and <italic>GNLY</italic> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1c</xref>). The results were consistent across the three subtypes, suggesting that the results in total NK population were contributed by all three subtypes and not affected by a single composition. Additionally, the proportion of NK cell was higher in CASE, while the proportion of NK_FCER1G and NK_KLRC1 was higher and the proportion of NK_FCGR3A was lower in CASE (<xref ref-type="fig" rid="fig3">Figure 3b</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1d</xref>). The respective transcriptome profile was compared in CASE and CON. Consistently, <italic>KLRC1</italic> was top-ranking in all three subtypes among the significantly upregulated DEGs, while <italic>CCL4</italic> and genes encoding heat shock protein were top-ranking in all three subtypes among significantly downregulated DEGs (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1e</xref>). KLRC1 and TIGIT are inhibitory receptors expressed on NK cell surface, and their activation inhibits NK cell functions (<xref ref-type="bibr" rid="bib102">Zhang et al., 2018</xref>; <xref ref-type="bibr" rid="bib5">André et al., 2018</xref>). It was collectively indicated that WD patients have NK cells with exhausted status, which results in poor effector function.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Identification of natural killer (NK) cell exhaustion in Wilson’s disease (WD) patients.</title><p>(<bold>a</bold>) The violin plots showing the relative expression level of genes in NK cells between the two group. ***, p&lt;0.001; Wilcox test. (<bold>b</bold>) Representative immunofluorescence staining for NK cells marked by CD56 and expression of KLRC1 in liver tissues of WD and control. The nucleus is stained by DAPI. Scale bars, 100 μm for 40× and 50 μm for 100×. KLRC1<sup>+</sup> NK cells are highlighted by arrows. The bar chart showing the proportion of KLRC1<sup>+</sup> NK cells. Quantifications were performed by assessing three random fields per slide. Data are mean ± SD. Unpaired two-tailed t-test. (<bold>c</bold>) Gating strategy applied in flow cytometry. Upper: NK cells were determined by CD3<sup>-</sup>CD56<sup>+</sup>. Down: NK cells with positive indicators (KLRC1, TIGIT, and IFNγ) were recorded. (<bold>d</bold>) The bar charts showing the percentage of KLRC1<sup>+</sup> (WD, n=5; Control, n=5), TIGIT<sup>+</sup> (WD, n=3; Control, n=3), and IFNγ<sup>+</sup> (WD, n=4; Control, n=4) NK cells. Data are mean ± SD. Unpaired two-tailed t-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Identification of natural killer (NK) cell exhaustion in Wilson’s disease (WD) patients.</title><p>(<bold>a</bold>) The dot plot showing Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment on differentially expressed genes (DEGs) in NK cells between CASE and CON. (<bold>b</bold>) The dot plot showing Gene Ontology (GO) enrichment on DEGs in NK cells between CASE and CON. BP, biological processes; CC, cellular components; MF, molecular function. (<bold>c</bold>) The heatmap showing the relative expression level of genes in three NK subtypes. The color represents the relative expression level. ns, not significant; *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001; Wilcox test. (<bold>d</bold>) The bar chart showing the proportion of three subtypes of NK cells in the two group. (<bold>e</bold>) The heatmap showing the top 20 DEGs for three subtypes of NK cells. (<bold>f</bold>) The plot showing trajectories of NK cells in CASE and CON. Upper: respective trajectory. Down: merged trajectory. (<bold>g</bold>) The heatmap showing the expression of genes in three clusters in pseudotime. The cell fate is divided into two directions, and left represents fate 1 and right represents fate 2. The expression level of genes in three clusters was represented by colors. See full gene list in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>. (<bold>h</bold>) The heatmap showing the average expression of top 10 regulons in NK cells in CASE and CON. (<bold>i</bold>) The bar charts showing the percentage of NK cells (WD, n=6; Control, n=7) and CD56<sup>Bright</sup> NK cells (WD, n=7; Control, n=7). Data are mean ± SD. Unpaired two-tailed t-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig5-figsupp1-v1.tif"/></fig></fig-group><p>In addition, trajectory analysis showed that NK cells in two groups exhibited a distinct differentiation trajectory. Most of the NK cells in CON differentiated toward cell fate 1, while those in CASE displayed a higher tendency for differentiation toward cell fate 2, with cell grouping occurring at the final stage (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1f</xref>). To ascertain the gene expression profile and the respective cell statuses of the two outcomes, we conducted pseudotime analysis of gene expression in two differentiating directions. The results showed that the gene expression of <italic>KLRC1</italic> (included in gene cluster 1) was gradually increased along the way to cell fate 2, while the gene expression of <italic>FCGR3A</italic>, <italic>TNF</italic>, and <italic>GZMB</italic> (included in gene cluster 3) was weakened in the same direction, suggesting that cell fate 2 is a more exhausted state of NK cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1g</xref>, see full gene list in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Consequently, these results demonstrate that NK cells differentiate toward an exhausted status in WD patients. The development, maturation, and function of NK cells are strictly regulated by transcription factors (TFs) (<xref ref-type="bibr" rid="bib13">Brillantes and Beaulieu, 2019</xref>). Next, to assess the TFs underlying differences in NK cells between CASE and CON, we applied PYSCENIC analysis in NK cells. We found that the gene expression of T-bet (encoded by <italic>TBX21</italic>) was downregulated and Eomes (encoded by <italic>EOMES</italic>) was upregulated in CASE (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1h</xref>). These two constitute a pair of TFs that play significantly complementary roles in directing the transcriptional program of NK cells. Consistent with previous studies, T-bet expression was downregulated in exhausted NK cells, whereas Eomes expression was increased (<xref ref-type="bibr" rid="bib80">Sun et al., 2019</xref>; <xref ref-type="bibr" rid="bib106">Zhang et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">da Silva et al., 2014</xref>).</p><p>To validate NK cell exhaustion in WD patients, we performed mIHC staining on liver tissue sections and flow cytometry on peripheral blood samples. The mIHC results indicated that KLRC1<sup>+</sup> cells were more frequently observed in NK cells marked by CD56 in the liver tissue sections of WD patients (<xref ref-type="fig" rid="fig5">Figure 5b</xref>). Moreover, flow cytometry was also performed to test the number and indicators expression of NK cell from the peripheral blood. After isolation from peripheral blood, NK cells were determined by CD3<sup>-</sup>CD56<sup>+</sup> and NK cells with positive indicators (KLRC1, TIGIT, and IFNγ) were recorded (<xref ref-type="fig" rid="fig5">Figure 5c</xref>). The results showed a significant increase in the percentage of KLRC1<sup>+</sup> and TIGIT<sup>+</sup> NK cells and a significant decrease in the percentage of IFNγ<sup>+</sup> NK cells in peripheral blood lymphocytes from WD patients (<xref ref-type="fig" rid="fig5">Figure 5d</xref>). Meanwhile, the proportion of NK cells in lymphocytes from peripheral blood and the proportion of CD56<sup>Bright</sup> NK cells in total NK cells were also calculated. The significantly higher proportion of NK cells in WD patients was consistent with the scRNA-seq data, and more CD56<sup>Bright</sup> NK cells suggested a relatively weaker effector function in WD patients (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1i</xref>). Therefore, these results indicated that, despite the increased proportion and the upregulated oxidative phosphorylation, NK cell exhibited exhausted status in WD patients.</p></sec><sec id="s2-6"><title>NK cell exhaustion predicts poor prognosis of cholecystitis</title><p>Cholecystitis patients with WD exhibit poorer clinical outcomes. There is evidence demonstrating that NK cell exhaustion is correlated with poor liver cancer prognosis (<xref ref-type="bibr" rid="bib80">Sun et al., 2019</xref>; <xref ref-type="bibr" rid="bib79">Sun et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Sun et al., 2015</xref>). Thus, we hypothesize that NK cell exhaustion also contributes to the worse prognosis of cholecystitis patients with WD.</p><p>Prognostic models for inflammatory-related diseases in GEO were developed using machine learning methods, including random survival forest, receiver operating characteristic (ROC) curve, and Kaplan-Meier survival curves. A logistic regression algorithm was used to construct a multigene prediction model based on GSE166915 (cholecystitis) and other inflammatory diseases, namely GSE91035 (pancreatitis), GSE75037 (lung adenocarcinoma), and GSE41804 (hepatocellular carcinoma). Using stepwise regression analysis, 12 genes, <italic>KLRC1</italic>, <italic>TIGIT</italic>, <italic>HAVCR2</italic>, <italic>PDCD1</italic>, <italic>CD96</italic>, <italic>LAG3</italic>, <italic>FCGR3A</italic>, <italic>NCR3</italic>, <italic>NCR2</italic>, <italic>NCR1</italic>, <italic>KLRK1</italic>, and <italic>PRF1</italic>, were selected to obtain the best model. The results showed that the predictive model constructed from these genes had good prognostic performance, with AUC of 0.77, 0.80, 0.97, 0.90 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1a–d</xref>). The AUCs of the models in GSE75037 and GSE41084 were relatively high, 0.97 and 0.90, respectively.</p><p>Univariate Cox regression analysis revealed that the <italic>TIGIT</italic> (in GSE166915) and <italic>PDCD1</italic> (in GSE75037) were risk genes with hazard ratio (HR)&gt;1, while <italic>NCR2</italic> (in GSE91035), <italic>HAVCR2</italic>, <italic>KLRC1</italic>, <italic>NCR3</italic> (in GSE75037), <italic>NCR3</italic>, <italic>LAG3</italic> (in GSE41804) were protective gene with HR&lt;1 among 12 differently expressed markers of NK cell exhaustion (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1a–d</xref>). Consistently, the Kaplan-Meier survival curves suggested a shorter survival time in the group with high markers of NK cell exhaustion than in the group with low markers in the GSE166915 (p=6.1e-6), GSE91035 (p=1.9e-5), GSE75037 (p=3.8e-16), and GSE41804 (p=3.0e-3) datasets (<xref ref-type="fig" rid="fig6">Figure 6a–d</xref>). Patients with cholecystitis, pancreatitis, lung adenocarcinoma, and hepatocellular carcinoma who show high markers of NK cell exhaustion are associated with poor survival compared to those with low markers of NK cell exhaustion.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Natural killer (NK) cell exhaustion predicts poor prognosis of inflammatory diseases.</title><p>(<bold>a–d</bold>) Kaplan-Meier survival curves for cholecystitis, pancreatitis, lung adenocarcinoma, and hepatocellular carcinoma according to the markers of NK cell exhaustion in the GSE166915, GSE91035, GSE75037, and GSE41804 datasets.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Predictive model construction for natural killer (NK) cell exhaustion.</title><p>(<bold>a–d</bold>) Receiver operating characteristic (ROC) curve analysis of prognostic-related markers of NK cell exhaustion and corresponding AUC values for the expression cohorts (left). Forest plot of prognostic-related markers of NK cell exhaustion based on univariate Cox regression analysis (right).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98867-fig6-figsupp1-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Immune cell dysfunction impacts the development, progression, and prognosis of diseases and serves as the basis for immunotherapy. The current understanding of immune cell dysfunction in inflammatory diseases is limited, which hinders the development of effective therapeutic strategies. Our retrospective clinical analysis indicates that WD contributes to the unfavorable prognosis of cholecystitis. We developed an atlas of immune cell dysfunction linked to specific metabolic disruption in WD patients, including 19 major cell types. The immune microenvironment change primarily encompasses increased proportion and strengthened function in innate immunocytes, including upregulated antigen processing and presentation and activation of immune responses. Furthermore, we conducted a comprehensive assessment and comparison of immune cell function in WD patients and control group. This includes an evaluation of pro-inflammatory and immune regulatory function in macrophages and KCs, phagocytosis and chemokine activity in neutrophils, and cytotoxicity in T cells, etc. We identified NK cell exhaustion in the WD patients, with upregulation of <italic>KLRC1</italic> and <italic>TIGIT</italic> and downregulation of <italic>CD16</italic>, <italic>TNF</italic>, <italic>IFNG</italic>, <italic>GZMB</italic>, <italic>GNLY</italic>, and <italic>CCL4</italic>. The validation of our findings in patient liver tissues and blood samples was conducted using immunohistochemistry assays and flow cytometry. Our findings indicated that the NK cell exhaustion signature has the ability to predict and prognosticate inflammatory diseases such as cholecystitis, pancreatitis, lung adenocarcinoma, and hepatocellular carcinoma. These results unveil novel perspectives on the immune cell dysfunction role in inflammatory diseases.</p><p>WD represents a model of metabolic abnormality in hepatocytes caused by <italic>ATP7B</italic> mutation. Therefore, immune cell dysfunction was induced by the extracellular signals within the reshaped tissue microenvironment. Emerging research indicates that metabolic crosstalk in the tumor microenvironment disrupts metabolic and signaling pathways in immune cells, leading to dysfunction (<xref ref-type="bibr" rid="bib41">Hosseini et al., 2022</xref>; <xref ref-type="bibr" rid="bib65">Park et al., 2023</xref>; <xref ref-type="bibr" rid="bib97">Yan et al., 2023</xref>; <xref ref-type="bibr" rid="bib8">Bader et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Riera-Domingo et al., 2020</xref>). Targeting metabolic pathways to enhance the efficacy of immunotherapy is a promising approach. Our study found multiple metabolic abnormalities in immune cells, including the widely upregulated ATP metabolic process in T and NK cells. Interestingly, glycolysis and oxidative phosphorylation contribute to maintain the cytotoxic ability and promote expansion of NK cells (<xref ref-type="bibr" rid="bib94">Wu et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Poznanski and Ashkar, 2019</xref>; <xref ref-type="bibr" rid="bib63">O’Brien and Finlay, 2019</xref>). However, high rate of oxidative phosphorylation, increased proportion, and exhausted status were simultaneously observed in NK cells of WD patients. Further studies are needed to elucidate the metabolic landscape, mechanisms underlying metabolic alterations, and their role in immune cell dysfunction.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Patients and clinical samples</title><p>All the clinical data were obtained from The First Affiliated Hospital of Anhui University of Chinese Medicine. The whole blood samples and liver tissue samples were collected from patients at The First Affiliated Hospital of Anhui University of Chinese Medicine. The study was approved by the Ethics Committee of the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine (approval number 2019AH-32), and the clinical study design, informed consent, and case report were also approved in the document.</p></sec><sec id="s4-2"><title>Sanger sequencing</title><p>The Sanger sequencing on 20 WD patients were conducted by Sangon Biotech (Shanghai) Co., Ltd.</p><p>The primers to detect mutations are:</p><list list-type="simple"><list-item><p>R778L-F, 5'-<named-content content-type="sequence">AGCCTTCACTGTCCTTGTCTTTC</named-content>-3';</p></list-item><list-item><p>R778L-R, 5'-<named-content content-type="sequence">ATTAGCTGGGATTTCAGAAGTAGTG</named-content>-3';</p></list-item><list-item><p>T935M-F, 5'-<named-content content-type="sequence">ATGCTTGTGGTGTTTTATTTCTTC</named-content>-3';</p></list-item><list-item><p>T935M-R, 5'-<named-content content-type="sequence">AGAAGCAAGCAAATAAAATGTAATG</named-content>-3';</p></list-item><list-item><p>P992L-F, 5'-<named-content content-type="sequence">TCTCAACCTGCCTCTGACTCTG</named-content>-3';</p></list-item><list-item><p>P992L-R, 5'-<named-content content-type="sequence">TGGTGGCTACTCTGTTGCTACTG</named-content>-3'.</p></list-item></list></sec><sec id="s4-3"><title>Cell culture, gene knockout, and metabolic assays</title><p>WRL 68 cells (purchased from Guangzhou Cellcook Biotech Co., Ltd.) were cultured using DMEM high-glucose media supplemented with 10% FBS at 37°C with 5% CO<sub>2</sub>. The lentivirus-mediated CRISPR-Cas9 KO vector targeting human <italic>ATP7B</italic> was obtained from OBiO Technology (Shanghai) Co., Ltd. Cells at 30–40% confluency were incubated in a medium containing optimal dilutions of lentivirus, then subjected to puromycin selection to obtain the stable transfected cells. OCRs and ECARs were measured using Seahorse XF Cell Mito Stress Test Kit (103015-100, Agilent) and Seahorse XF Glycolysis Stress Test Kit (103020-100, Agilent) according to manuals in Agilent XFe96 Analyzer, respectively.</p></sec><sec id="s4-4"><title>Single-cell RNA-sequencing</title><p>In the cell preparation section: For the quality check and counting of single-cell suspension, the cell survival rate is generally above 80%. The cells that have passed the test are washed and resuspended to prepare a suitable cell concentration of 700–1200 cells/μL for 10x Genomics Chromium. The system is operated on the machine.</p><p>Steps in GEM Creation and Thermal Cycling: GEMs (Gel Bead in Emulsion) were constructed for single-cell separation according to the number of cells to be harvested. After GEMs were normally formed, GEMs were collected for reverse transcription in a PCR machine for labeling.</p><p>Post Cycling Cleanup and cDNA Amplication: The GEMs were oil-treated, and the amplified cDNA was purified by magnetic beads, and then subjected to cDNA amplification and quality inspection.</p><p>Library Preparation and Quantification: The 3’Gene Expression Library was constructed with the quality-qualified cDNA. After fragmentation, adaptor ligation, sample index PCR, etc., the library is finally quantitatively examined.</p><p>Sequencing: The final library pool was sequenced on the Illumina HiSeq instrument using 150-base-pair paired-end reads.</p></sec><sec id="s4-5"><title>Pathway enrichment analysis</title><p>To investigate the potential functions of DEGs, the GO and KEGG analysis were used with the ‘clusterProfiler’ R package 3.16.1 (<xref ref-type="bibr" rid="bib99">Yu et al., 2012</xref>). Pathways with p_adj value less than 0.05 were considered as significantly enriched. GO gene sets including molecular function, biological process, and cellular component categories were used as reference.</p></sec><sec id="s4-6"><title>Cell-cell interaction analysis</title><p>CellChat (version 0.0.2) was used to analyze the intercellular communication networks from scRNA-seq data (<xref ref-type="bibr" rid="bib46">Jin et al., 2021</xref>). A CellChat object was created using the R package process. Cell information was added into the meta slot of the object. The ligand-receptor interaction database was set, and the matching receptor inference calculation was performed.</p></sec><sec id="s4-7"><title>Trajectory analysis</title><p>Cell differentiation trajectory was reconstructed with Monocle2 (<xref ref-type="bibr" rid="bib69">Qiu et al., 2017</xref>). Highly variable genes were used to sort cells in order of spatial‐temporal differentiation. We used DDRTree to perform FindVairableFeatures and dimension reduction. Finally, the trajectory was visualized by plot_cell_trajectory function. Next, CytoTRACE (a computational method that predicts the differentiation state of cells from scRNA-seq data using gene Counts and Expression) was used to predict the differentiation potential (<xref ref-type="bibr" rid="bib35">Gulati et al., 2020</xref>).</p></sec><sec id="s4-8"><title>TF regulatory network analysis</title><p>TF network was constructed by pyscenic v0.11.0 using scRNA expression matrix and TFs in AnimalTFDB (<xref ref-type="bibr" rid="bib84">Van de Sande et al., 2020</xref>). First, GRNBoost2 predicted a regulatory network based on the co-expression of regulators and targets. CisTarget was then applied to exclude indirect targets and to search TF binding motifs. After that, AUCell was used for regulon activity quantification for every cell.</p></sec><sec id="s4-9"><title>UCell gene set scoring</title><p>Gene set scoring was performed using the R package UCell v 1.1.0 (<xref ref-type="bibr" rid="bib6">Andreatta and Carmona, 2021</xref>). UCell scores are based on the Mann-Whitney U statistic by ranking query genes in order of their expression levels in individual cells. Because UCell is a rank-based scoring method, it is suitable to be used in large datasets containing multiple samples and batches. The gene sets for signature scoring are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>.</p></sec><sec id="s4-10"><title>Cell type annotation and DEGs analysis</title><p>The cell type identity of each cluster was determined with the expression of canonical markers found in the DEGs using SynEcoSys database. The markers and references are shown in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>. To identify DEGs, we used the Seurat FindMarkers function based on Wilcox likelihood-ratio test with default parameters, and selected the genes expressed in more than 10% of the cells in a cluster and with an average log (Fold Change) value greater than 0.25 as DEGs. For the cell type annotation of each cluster, we combined the expression of canonical markers found in the DEGs with knowledge from literature, and displayed the expression of markers of each cell type with heatmaps that were generated with Seurat Heatmap function. Doublet cells were identified as expressing markers for different cell types, and removed manually.</p></sec><sec id="s4-11"><title>Multiplex immunohistochemistry</title><p>The procedure of deparaffinization, dehydration, antigen retrieval, endogenous peroxidases quench, block, antibody incubation was conducted as standard immunohistochemistry. Solution of tyramide signal amplification (TSA) (WAS1101010, BioMed World) was applied on the slides and antibodies were removed by microwave heating. Repeat block, antibody incubation, TSA, and microwave heating to perform next cycle of staining. DAPI (WAS1301050, BioMed World) was used to stain nuclei and antifade mountant (WAS1302050, BioMed World) was applied. The primary antibody to CD56 (ab75813, Abcam) and KLRC1 (ab260035, Abcam) and secondary antibody (WAS1201100, BioMed World) were used. Image of immunofluorescence-stained slides were acquired with Nikon Eclipse Ci-L and 3DHISTECH Pannoramic MIDI II.</p></sec><sec id="s4-12"><title>Flow cytometry</title><p>Lymphocytes were isolated from the whole blood using density gradient centrifugal method (P8610, Solarbio). Isolated cells were blocked (564219, BD Pharmingen) and stained with antibodies against CD3 (560835, BD Pharmingen), CD56 (555518, BD Pharmingen), KLRC1 (375114, BioLegend), and TIGIT (568672, BD Pharmingen). For intracellular cytokine staining, cells were stimulated for 4 hr with Leukocyte Activation Cocktail and BD GolgiPlug (550583, BD Pharmingen) according to manuals. After stimulation, cells were blocked, stained for surface markers, fixed, and permeabilized with Fixation/Permeablization Kit (554714, BD Pharmingen). Fixed cells were stained with antibodies against IFNγ (552887, BD Pharmingen).</p></sec><sec id="s4-13"><title>Construction and verification of prognostic model</title><p>On the basis of the markers of NK cell exhaustion, univariate Cox analysis was conducted in cholecystitis, pancreatitis, lung adenocarcinoma, and hepatocellular carcinoma patients to screen survival-related markers of NK cell exhaustion, and markers with p-values&lt;0.05 were retained. We conducted multivariate analysis to identify the optimal prognostic markers for the prognostic model. The risk scores of the patients were calculated based on the normalized gene expression levels and the Cox regression coefficients of selected markers. Time-dependent ROC curves were utilized to verify the prognostic performance of the model for overall survival. For Kaplan-Meier survival, we used the R software package maxstat (maximally selected rank statistics with multiple p-value approximations version: 0.7–25) to calculate the optimal cutoff value for RiskScore. We set the minimum group sample size to be greater than 25% and the maximum group sample size to be less than 75%, ultimately obtaining the optimal cutoff value. Based on this, patients were divided into high and low groups, and further analyzed the prognostic differences between the two groups using the R software package’s survival function. The logrank test method was used to evaluate the significance of prognostic differences between different groups of samples, and significant prognostic differences were ultimately observed.</p></sec><sec id="s4-14"><title>Statistical analysis</title><p>Statistical analyses were performed using appropriate tests as indicated in legends (unpaired two-tailed t-test, chi-square test, and Wilcox test).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Validation, Visualization, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Validation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Software, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con4"><p>Resources, Data curation, Validation</p></fn><fn fn-type="con" id="con5"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con7"><p>Validation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Supervision</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Supervision, Funding acquisition</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The study was approved by the Ethics Committee of the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine (2019AH-32.32), and the clinical study design, informed consent , and case report were also approved in the document.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Supplementary informations for data analysis.</title><p>(a) The number and proportion of each cell type. This table shows the number and proportion of each cell type and each subtype in all samples. (b) The list of genes in each cluster. This table shows the gene ID included in three clusters, and the genes mentioned in the article are marked in yellow. (c) The list of genes used for signature scoring. This table shows the gene ID used for signature scoring. (d) The list of marker genes used for cell type annotation. This table shows the marker genes used for cell type and subtype annotation and the respective references.</p></caption><media xlink:href="elife-98867-supp1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-98867-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>sc-RNA sequencing data that support the findings of this study have been deposited in Gene Expression Omnibus (GEO) with the accession number GSE254082.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Tao</surname><given-names>Q</given-names></name><name><surname>Hou</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name></person-group><source>NCBI BioProject</source><year iso-8601-date="2024">2024</year><data-title>NK Cell Exhaustion in Wilson’s Disease Revealed by Single-cell RNA Sequencing Predicts the Prognosis of Cholecystitis</data-title><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=GSE254082">GSE254082</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by grants from National Natural Science foundation of China (Project: 2021KY340; NSFC: 81773112 and 82073186 for QF). This work was supported by Construction project of the State Administration of Traditional Chinese Medicine in 2021 (Teaching Letter [2021] No. 270 for QY) and Anhui Province Clinical Key Specialty Project in 2022 (Anhui Weichuan [2022] No. 297 for QY).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abel</surname><given-names>AM</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Thakar</surname><given-names>MS</given-names></name><name><surname>Malarkannan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Natural killer cells: development, maturation, and clinical utilization</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>1869</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01869</pub-id><pub-id pub-id-type="pmid">30150991</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Sbeih</surname><given-names>H</given-names></name><name><surname>Tran</surname><given-names>CN</given-names></name><name><surname>Ge</surname><given-names>PS</given-names></name><name><surname>Bhutani</surname><given-names>MS</given-names></name><name><surname>Alasadi</surname><given-names>M</given-names></name><name><surname>Naing</surname><given-names>A</given-names></name><name><surname>Jazaeri</surname><given-names>AA</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment</article-title><source>Journal for Immunotherapy of Cancer</source><volume>7</volume><elocation-id>118</elocation-id><pub-id pub-id-type="doi">10.1186/s40425-019-0604-2</pub-id><pub-id pub-id-type="pmid">31053161</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>A</given-names></name><name><surname>Bhatt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Wilson disease</article-title><source>Current Opinion in Neurology</source><volume>33</volume><fpage>534</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1097/WCO.0000000000000837</pub-id><pub-id pub-id-type="pmid">32657896</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andor</surname><given-names>N</given-names></name><name><surname>Simonds</surname><given-names>EF</given-names></name><name><surname>Czerwinski</surname><given-names>DK</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Grimes</surname><given-names>SM</given-names></name><name><surname>Wood-Bouwens</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>GXY</given-names></name><name><surname>Kubit</surname><given-names>MA</given-names></name><name><surname>Greer</surname><given-names>S</given-names></name><name><surname>Weiss</surname><given-names>WA</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name><name><surname>Ji</surname><given-names>HP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints</article-title><source>Blood</source><volume>133</volume><fpage>1119</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1182/blood-2018-08-862292</pub-id><pub-id pub-id-type="pmid">30591526</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>André</surname><given-names>P</given-names></name><name><surname>Denis</surname><given-names>C</given-names></name><name><surname>Soulas</surname><given-names>C</given-names></name><name><surname>Bourbon-Caillet</surname><given-names>C</given-names></name><name><surname>Lopez</surname><given-names>J</given-names></name><name><surname>Arnoux</surname><given-names>T</given-names></name><name><surname>Bléry</surname><given-names>M</given-names></name><name><surname>Bonnafous</surname><given-names>C</given-names></name><name><surname>Gauthier</surname><given-names>L</given-names></name><name><surname>Morel</surname><given-names>A</given-names></name><name><surname>Rossi</surname><given-names>B</given-names></name><name><surname>Remark</surname><given-names>R</given-names></name><name><surname>Breso</surname><given-names>V</given-names></name><name><surname>Bonnet</surname><given-names>E</given-names></name><name><surname>Habif</surname><given-names>G</given-names></name><name><surname>Guia</surname><given-names>S</given-names></name><name><surname>Lalanne</surname><given-names>AI</given-names></name><name><surname>Hoffmann</surname><given-names>C</given-names></name><name><surname>Lantz</surname><given-names>O</given-names></name><name><surname>Fayette</surname><given-names>J</given-names></name><name><surname>Boyer-Chammard</surname><given-names>A</given-names></name><name><surname>Zerbib</surname><given-names>R</given-names></name><name><surname>Dodion</surname><given-names>P</given-names></name><name><surname>Ghadially</surname><given-names>H</given-names></name><name><surname>Jure-Kunkel</surname><given-names>M</given-names></name><name><surname>Morel</surname><given-names>Y</given-names></name><name><surname>Herbst</surname><given-names>R</given-names></name><name><surname>Narni-Mancinelli</surname><given-names>E</given-names></name><name><surname>Cohen</surname><given-names>RB</given-names></name><name><surname>Vivier</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells</article-title><source>Cell</source><volume>175</volume><fpage>1731</fpage><lpage>1743</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.10.014</pub-id><pub-id pub-id-type="pmid">30503213</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreatta</surname><given-names>M</given-names></name><name><surname>Carmona</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>UCell: robust and scalable single-cell gene signature scoring</article-title><source>Computational and Structural Biotechnology Journal</source><volume>19</volume><fpage>3796</fpage><lpage>3798</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2021.06.043</pub-id><pub-id pub-id-type="pmid">34285779</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>MJ</given-names></name><name><surname>Adams</surname><given-names>LA</given-names></name><name><surname>Canbay</surname><given-names>A</given-names></name><name><surname>Syn</surname><given-names>WK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Extrahepatic complications of nonalcoholic fatty liver disease</article-title><source>Hepatology</source><volume>59</volume><fpage>1174</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1002/hep.26717</pub-id><pub-id pub-id-type="pmid">24002776</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bader</surname><given-names>JE</given-names></name><name><surname>Voss</surname><given-names>K</given-names></name><name><surname>Rathmell</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy</article-title><source>Molecular Cell</source><volume>78</volume><fpage>1019</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.05.034</pub-id><pub-id pub-id-type="pmid">32559423</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandmann</surname><given-names>O</given-names></name><name><surname>Weiss</surname><given-names>KH</given-names></name><name><surname>Kaler</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Wilson’s disease and other neurological copper disorders</article-title><source>The Lancet. Neurology</source><volume>14</volume><fpage>103</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(14)70190-5</pub-id><pub-id pub-id-type="pmid">25496901</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassez</surname><given-names>A</given-names></name><name><surname>Vos</surname><given-names>H</given-names></name><name><surname>Van Dyck</surname><given-names>L</given-names></name><name><surname>Floris</surname><given-names>G</given-names></name><name><surname>Arijs</surname><given-names>I</given-names></name><name><surname>Desmedt</surname><given-names>C</given-names></name><name><surname>Boeckx</surname><given-names>B</given-names></name><name><surname>Vanden Bempt</surname><given-names>M</given-names></name><name><surname>Nevelsteen</surname><given-names>I</given-names></name><name><surname>Lambein</surname><given-names>K</given-names></name><name><surname>Punie</surname><given-names>K</given-names></name><name><surname>Neven</surname><given-names>P</given-names></name><name><surname>Garg</surname><given-names>AD</given-names></name><name><surname>Wildiers</surname><given-names>H</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Smeets</surname><given-names>A</given-names></name><name><surname>Lambrechts</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer</article-title><source>Nature Medicine</source><volume>27</volume><fpage>820</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01323-8</pub-id><pub-id pub-id-type="pmid">33958794</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharjee</surname><given-names>S</given-names></name><name><surname>Hamberger</surname><given-names>F</given-names></name><name><surname>Ravichandra</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Nair</surname><given-names>A</given-names></name><name><surname>Affo</surname><given-names>S</given-names></name><name><surname>Filliol</surname><given-names>A</given-names></name><name><surname>Chin</surname><given-names>L</given-names></name><name><surname>Savage</surname><given-names>TM</given-names></name><name><surname>Yin</surname><given-names>D</given-names></name><name><surname>Wirsik</surname><given-names>NM</given-names></name><name><surname>Mehal</surname><given-names>A</given-names></name><name><surname>Arpaia</surname><given-names>N</given-names></name><name><surname>Seki</surname><given-names>E</given-names></name><name><surname>Mack</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>D</given-names></name><name><surname>Sims</surname><given-names>PA</given-names></name><name><surname>Kalluri</surname><given-names>R</given-names></name><name><surname>Stanger</surname><given-names>BZ</given-names></name><name><surname>Olive</surname><given-names>KP</given-names></name><name><surname>Schmidt</surname><given-names>T</given-names></name><name><surname>Wells</surname><given-names>RG</given-names></name><name><surname>Mederacke</surname><given-names>I</given-names></name><name><surname>Schwabe</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e146987</elocation-id><pub-id pub-id-type="doi">10.1172/JCI146987</pub-id><pub-id pub-id-type="pmid">33905375</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>NK cell exhaustion</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>760</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00760</pub-id><pub-id pub-id-type="pmid">28702032</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brillantes</surname><given-names>M</given-names></name><name><surname>Beaulieu</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcriptional control of natural killer cell differentiation</article-title><source>Immunology</source><volume>156</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1111/imm.13017</pub-id><pub-id pub-id-type="pmid">30450565</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buonacera</surname><given-names>A</given-names></name><name><surname>Stancanelli</surname><given-names>B</given-names></name><name><surname>Colaci</surname><given-names>M</given-names></name><name><surname>Malatino</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases</article-title><source>International Journal of Molecular Sciences</source><volume>23</volume><elocation-id>3636</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23073636</pub-id><pub-id pub-id-type="pmid">35408994</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Gamini</surname><given-names>R</given-names></name><name><surname>Sécca</surname><given-names>C</given-names></name><name><surname>Collins</surname><given-names>PL</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Peng</surname><given-names>V</given-names></name><name><surname>Robinette</surname><given-names>ML</given-names></name><name><surname>Schettini</surname><given-names>J</given-names></name><name><surname>Zaitsev</surname><given-names>K</given-names></name><name><surname>Gordon</surname><given-names>W</given-names></name><name><surname>Bando</surname><given-names>JK</given-names></name><name><surname>Yomogida</surname><given-names>K</given-names></name><name><surname>Cortez</surname><given-names>V</given-names></name><name><surname>Fronick</surname><given-names>C</given-names></name><name><surname>Fulton</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>LL</given-names></name><name><surname>Gilfillan</surname><given-names>S</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Shan</surname><given-names>L</given-names></name><name><surname>Artyomov</surname><given-names>MN</given-names></name><name><surname>Bowman</surname><given-names>M</given-names></name><name><surname>Oltz</surname><given-names>EM</given-names></name><name><surname>Jelinsky</surname><given-names>SA</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues</article-title><source>Nature Immunology</source><volume>20</volume><fpage>980</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0425-y</pub-id><pub-id pub-id-type="pmid">31209406</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y-P</given-names></name><name><surname>Yin</surname><given-names>J-H</given-names></name><name><surname>Li</surname><given-names>W-F</given-names></name><name><surname>Li</surname><given-names>H-J</given-names></name><name><surname>Chen</surname><given-names>D-P</given-names></name><name><surname>Zhang</surname><given-names>C-J</given-names></name><name><surname>Lv</surname><given-names>J-W</given-names></name><name><surname>Wang</surname><given-names>Y-Q</given-names></name><name><surname>Li</surname><given-names>X-M</given-names></name><name><surname>Li</surname><given-names>J-Y</given-names></name><name><surname>Zhang</surname><given-names>P-P</given-names></name><name><surname>Li</surname><given-names>Y-Q</given-names></name><name><surname>He</surname><given-names>Q-M</given-names></name><name><surname>Yang</surname><given-names>X-J</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>L-L</given-names></name><name><surname>Zhou</surname><given-names>G-Q</given-names></name><name><surname>Mao</surname><given-names>Y-P</given-names></name><name><surname>Wei</surname><given-names>C</given-names></name><name><surname>Xiong</surname><given-names>K-X</given-names></name><name><surname>Zhang</surname><given-names>H-B</given-names></name><name><surname>Zhu</surname><given-names>S-D</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Dean</surname><given-names>M</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Kuang</surname><given-names>D-M</given-names></name><name><surname>Li</surname><given-names>G-B</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma</article-title><source>Cell Research</source><volume>30</volume><fpage>1024</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1038/s41422-020-0374-x</pub-id><pub-id pub-id-type="pmid">32686767</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Ouyang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>S100A8 and S100A9 in cancer</article-title><source>Biochimica et Biophysica Acta. Reviews on Cancer</source><volume>1878</volume><elocation-id>188891</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbcan.2023.188891</pub-id><pub-id pub-id-type="pmid">37001615</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale chinese patients with wilson disease</article-title><source>Clinical Genetics</source><volume>92</volume><fpage>69</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1111/cge.12951</pub-id><pub-id pub-id-type="pmid">27982432</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>Y</given-names></name><name><surname>Szabo</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Two faces of neutrophils in liver disease development and progression</article-title><source>Hepatology</source><volume>74</volume><fpage>503</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1002/hep.31680</pub-id><pub-id pub-id-type="pmid">33314193</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crinier</surname><given-names>A</given-names></name><name><surname>Narni-Mancinelli</surname><given-names>E</given-names></name><name><surname>Ugolini</surname><given-names>S</given-names></name><name><surname>Vivier</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SnapShot: natural killer cells</article-title><source>Cell</source><volume>180</volume><elocation-id>1280</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.029</pub-id><pub-id pub-id-type="pmid">32200803</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crispe</surname><given-names>IN</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The liver as a lymphoid organ</article-title><source>Annual Review of Immunology</source><volume>27</volume><fpage>147</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132629</pub-id><pub-id pub-id-type="pmid">19302037</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Członkowska</surname><given-names>A</given-names></name><name><surname>Litwin</surname><given-names>T</given-names></name><name><surname>Dusek</surname><given-names>P</given-names></name><name><surname>Ferenci</surname><given-names>P</given-names></name><name><surname>Lutsenko</surname><given-names>S</given-names></name><name><surname>Medici</surname><given-names>V</given-names></name><name><surname>Rybakowski</surname><given-names>JK</given-names></name><name><surname>Weiss</surname><given-names>KH</given-names></name><name><surname>Schilsky</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Wilson disease</article-title><source>Nature Reviews. Disease Primers</source><volume>4</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.1038/s41572-018-0018-3</pub-id><pub-id pub-id-type="pmid">30190489</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>IP</given-names></name><name><surname>Gallois</surname><given-names>A</given-names></name><name><surname>Jimenez-Baranda</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>AC</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name><name><surname>Osman</surname><given-names>I</given-names></name><name><surname>Bhardwaj</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade</article-title><source>Cancer Immunology Research</source><volume>2</volume><fpage>410</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.CIR-13-0171</pub-id><pub-id pub-id-type="pmid">24795354</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depuydt</surname><given-names>MAC</given-names></name><name><surname>Prange</surname><given-names>KHM</given-names></name><name><surname>Slenders</surname><given-names>L</given-names></name><name><surname>Örd</surname><given-names>T</given-names></name><name><surname>Elbersen</surname><given-names>D</given-names></name><name><surname>Boltjes</surname><given-names>A</given-names></name><name><surname>de Jager</surname><given-names>SCA</given-names></name><name><surname>Asselbergs</surname><given-names>FW</given-names></name><name><surname>de Borst</surname><given-names>GJ</given-names></name><name><surname>Aavik</surname><given-names>E</given-names></name><name><surname>Lönnberg</surname><given-names>T</given-names></name><name><surname>Lutgens</surname><given-names>E</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>den Ruijter</surname><given-names>HM</given-names></name><name><surname>Kaikkonen</surname><given-names>MU</given-names></name><name><surname>Bot</surname><given-names>I</given-names></name><name><surname>Slütter</surname><given-names>B</given-names></name><name><surname>van der Laan</surname><given-names>SW</given-names></name><name><surname>Yla-Herttuala</surname><given-names>S</given-names></name><name><surname>Mokry</surname><given-names>M</given-names></name><name><surname>Kuiper</surname><given-names>J</given-names></name><name><surname>de Winther</surname><given-names>MPJ</given-names></name><name><surname>Pasterkamp</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics</article-title><source>Circulation Research</source><volume>127</volume><fpage>1437</fpage><lpage>1455</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.120.316770</pub-id><pub-id pub-id-type="pmid">32981416</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>LJ</given-names></name><name><surname>Barnes</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Pritchard</surname><given-names>MT</given-names></name><name><surname>Nagy</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Kupffer cells in the liver</article-title><source>Comprehensive Physiology</source><volume>3</volume><fpage>785</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1002/cphy.c120026</pub-id><pub-id pub-id-type="pmid">23720329</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumas</surname><given-names>SJ</given-names></name><name><surname>Meta</surname><given-names>E</given-names></name><name><surname>Borri</surname><given-names>M</given-names></name><name><surname>Goveia</surname><given-names>J</given-names></name><name><surname>Rohlenova</surname><given-names>K</given-names></name><name><surname>Conchinha</surname><given-names>NV</given-names></name><name><surname>Falkenberg</surname><given-names>K</given-names></name><name><surname>Teuwen</surname><given-names>LA</given-names></name><name><surname>de Rooij</surname><given-names>L</given-names></name><name><surname>Kalucka</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Taverna</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Parys</surname><given-names>M</given-names></name><name><surname>De Legher</surname><given-names>C</given-names></name><name><surname>Vinckier</surname><given-names>S</given-names></name><name><surname>Karakach</surname><given-names>TK</given-names></name><name><surname>Schoonjans</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Bolund</surname><given-names>L</given-names></name><name><surname>Dewerchin</surname><given-names>M</given-names></name><name><surname>Eelen</surname><given-names>G</given-names></name><name><surname>Rabelink</surname><given-names>TJ</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA sequencing reveals renal endothelium heterogeneity and metabolic adaptation to water deprivation</article-title><source>Journal of the American Society of Nephrology</source><volume>31</volume><fpage>118</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1681/ASN.2019080832</pub-id><pub-id pub-id-type="pmid">31818909</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durante</surname><given-names>MA</given-names></name><name><surname>Rodriguez</surname><given-names>DA</given-names></name><name><surname>Kurtenbach</surname><given-names>S</given-names></name><name><surname>Kuznetsov</surname><given-names>JN</given-names></name><name><surname>Sanchez</surname><given-names>MI</given-names></name><name><surname>Decatur</surname><given-names>CL</given-names></name><name><surname>Snyder</surname><given-names>H</given-names></name><name><surname>Feun</surname><given-names>LG</given-names></name><name><surname>Livingstone</surname><given-names>AS</given-names></name><name><surname>Harbour</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell analysis reveals new evolutionary complexity in uveal melanoma</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>496</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-14256-1</pub-id><pub-id pub-id-type="pmid">31980621</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earls</surname><given-names>RH</given-names></name><name><surname>Lee</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The role of natural killer cells in parkinson’s disease</article-title><source>Experimental &amp; Molecular Medicine</source><volume>52</volume><fpage>1517</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1038/s12276-020-00505-7</pub-id><pub-id pub-id-type="pmid">32973221</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmentaite</surname><given-names>R</given-names></name><name><surname>Kumasaka</surname><given-names>N</given-names></name><name><surname>Roberts</surname><given-names>K</given-names></name><name><surname>Fleming</surname><given-names>A</given-names></name><name><surname>Dann</surname><given-names>E</given-names></name><name><surname>King</surname><given-names>HW</given-names></name><name><surname>Kleshchevnikov</surname><given-names>V</given-names></name><name><surname>Dabrowska</surname><given-names>M</given-names></name><name><surname>Pritchard</surname><given-names>S</given-names></name><name><surname>Bolt</surname><given-names>L</given-names></name><name><surname>Vieira</surname><given-names>SF</given-names></name><name><surname>Mamanova</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Perrone</surname><given-names>F</given-names></name><name><surname>Goh Kai’En</surname><given-names>I</given-names></name><name><surname>Lisgo</surname><given-names>SN</given-names></name><name><surname>Katan</surname><given-names>M</given-names></name><name><surname>Leonard</surname><given-names>S</given-names></name><name><surname>Oliver</surname><given-names>TRW</given-names></name><name><surname>Hook</surname><given-names>CE</given-names></name><name><surname>Nayak</surname><given-names>K</given-names></name><name><surname>Campos</surname><given-names>LS</given-names></name><name><surname>Domínguez Conde</surname><given-names>C</given-names></name><name><surname>Stephenson</surname><given-names>E</given-names></name><name><surname>Engelbert</surname><given-names>J</given-names></name><name><surname>Botting</surname><given-names>RA</given-names></name><name><surname>Polanski</surname><given-names>K</given-names></name><name><surname>van Dongen</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Morgan</surname><given-names>MD</given-names></name><name><surname>Marioni</surname><given-names>JC</given-names></name><name><surname>Bayraktar</surname><given-names>OA</given-names></name><name><surname>Meyer</surname><given-names>KB</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Barker</surname><given-names>RA</given-names></name><name><surname>Uhlig</surname><given-names>HH</given-names></name><name><surname>Mahbubani</surname><given-names>KT</given-names></name><name><surname>Saeb-Parsy</surname><given-names>K</given-names></name><name><surname>Zilbauer</surname><given-names>M</given-names></name><name><surname>Clatworthy</surname><given-names>MR</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name><name><surname>James</surname><given-names>KR</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cells of the human intestinal tract mapped across space and time</article-title><source>Nature</source><volume>597</volume><fpage>250</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03852-1</pub-id><pub-id pub-id-type="pmid">34497389</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elwood</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cholecystitis</article-title><source>The Surgical Clinics of North America</source><volume>88</volume><fpage>1241</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1016/j.suc.2008.07.008</pub-id><pub-id pub-id-type="pmid">18992593</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>DM</given-names></name><name><surname>Rahman</surname><given-names>AH</given-names></name><name><surname>Fernandez</surname><given-names>NF</given-names></name><name><surname>Chudnovskiy</surname><given-names>A</given-names></name><name><surname>Amir</surname><given-names>EAD</given-names></name><name><surname>Amadori</surname><given-names>L</given-names></name><name><surname>Khan</surname><given-names>NS</given-names></name><name><surname>Wong</surname><given-names>CK</given-names></name><name><surname>Shamailova</surname><given-names>R</given-names></name><name><surname>Hill</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Remark</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>JR</given-names></name><name><surname>Pina</surname><given-names>C</given-names></name><name><surname>Faries</surname><given-names>C</given-names></name><name><surname>Awad</surname><given-names>AJ</given-names></name><name><surname>Moss</surname><given-names>N</given-names></name><name><surname>Bjorkegren</surname><given-names>JLM</given-names></name><name><surname>Kim-Schulze</surname><given-names>S</given-names></name><name><surname>Gnjatic</surname><given-names>S</given-names></name><name><surname>Ma’ayan</surname><given-names>A</given-names></name><name><surname>Mocco</surname><given-names>J</given-names></name><name><surname>Faries</surname><given-names>P</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Giannarelli</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell immune landscape of human atherosclerotic plaques</article-title><source>Nature Medicine</source><volume>25</volume><fpage>1576</fpage><lpage>1588</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0590-4</pub-id><pub-id pub-id-type="pmid">31591603</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fridman</surname><given-names>WH</given-names></name><name><surname>Zitvogel</surname><given-names>L</given-names></name><name><surname>Sautès-Fridman</surname><given-names>C</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The immune contexture in cancer prognosis and treatment</article-title><source>Nature Reviews. Clinical Oncology</source><volume>14</volume><fpage>717</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2017.101</pub-id><pub-id pub-id-type="pmid">28741618</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>YT</given-names></name><name><surname>Pang</surname><given-names>LW</given-names></name><name><surname>Dai</surname><given-names>WL</given-names></name><name><surname>Wu</surname><given-names>SD</given-names></name><name><surname>Kong</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Advances in the study of acute acalculous cholecystitis: a comprehensive review</article-title><source>Digestive Diseases</source><volume>40</volume><fpage>468</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1159/000520025</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L</given-names></name><name><surname>Kwong</surname><given-names>DLW</given-names></name><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Chow</surname><given-names>LKY</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>VHF</given-names></name><name><surname>Lam</surname><given-names>KO</given-names></name><name><surname>Lo</surname><given-names>AWI</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>AWM</given-names></name><name><surname>Guan</surname><given-names>XY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>1540</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21795-z</pub-id><pub-id pub-id-type="pmid">33750785</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulati</surname><given-names>GS</given-names></name><name><surname>Sikandar</surname><given-names>SS</given-names></name><name><surname>Wesche</surname><given-names>DJ</given-names></name><name><surname>Manjunath</surname><given-names>A</given-names></name><name><surname>Bharadwaj</surname><given-names>A</given-names></name><name><surname>Berger</surname><given-names>MJ</given-names></name><name><surname>Ilagan</surname><given-names>F</given-names></name><name><surname>Kuo</surname><given-names>AH</given-names></name><name><surname>Hsieh</surname><given-names>RW</given-names></name><name><surname>Cai</surname><given-names>S</given-names></name><name><surname>Zabala</surname><given-names>M</given-names></name><name><surname>Scheeren</surname><given-names>FA</given-names></name><name><surname>Lobo</surname><given-names>NA</given-names></name><name><surname>Qian</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>FB</given-names></name><name><surname>Dirbas</surname><given-names>FM</given-names></name><name><surname>Clarke</surname><given-names>MF</given-names></name><name><surname>Newman</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptional diversity is a hallmark of developmental potential</article-title><source>Science</source><volume>367</volume><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1126/science.aax0249</pub-id><pub-id pub-id-type="pmid">31974247</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halbritter</surname><given-names>F</given-names></name><name><surname>Farlik</surname><given-names>M</given-names></name><name><surname>Schwentner</surname><given-names>R</given-names></name><name><surname>Jug</surname><given-names>G</given-names></name><name><surname>Fortelny</surname><given-names>N</given-names></name><name><surname>Schnöller</surname><given-names>T</given-names></name><name><surname>Pisa</surname><given-names>H</given-names></name><name><surname>Schuster</surname><given-names>LC</given-names></name><name><surname>Reinprecht</surname><given-names>A</given-names></name><name><surname>Czech</surname><given-names>T</given-names></name><name><surname>Gojo</surname><given-names>J</given-names></name><name><surname>Holter</surname><given-names>W</given-names></name><name><surname>Minkov</surname><given-names>M</given-names></name><name><surname>Bauer</surname><given-names>WM</given-names></name><name><surname>Simonitsch-Klupp</surname><given-names>I</given-names></name><name><surname>Bock</surname><given-names>C</given-names></name><name><surname>Hutter</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Epigenomics and single-cell sequencing define a developmental hierarchy in langerhans cell histiocytosis</article-title><source>Cancer Discovery</source><volume>9</volume><fpage>1406</fpage><lpage>1421</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-19-0138</pub-id><pub-id pub-id-type="pmid">31345789</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>T</given-names></name><name><surname>Oakley</surname><given-names>F</given-names></name><name><surname>Anstee</surname><given-names>QM</given-names></name><name><surname>Day</surname><given-names>CP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Nonalcoholic fatty liver disease: pathogenesis and disease spectrum</article-title><source>Annual Review of Pathology</source><volume>11</volume><fpage>451</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1146/annurev-pathol-012615-044224</pub-id><pub-id pub-id-type="pmid">26980160</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>LH</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>YQ</given-names></name><name><surname>Chen</surname><given-names>HT</given-names></name><name><surname>Xu</surname><given-names>JH</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Lin</surname><given-names>GW</given-names></name><name><surname>Wei</surname><given-names>PP</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Bei</surname><given-names>JX</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptome profiling of an adult human cell atlas of 15 major organs</article-title><source>Genome Biology</source><volume>21</volume><elocation-id>294</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-020-02210-0</pub-id><pub-id pub-id-type="pmid">33287869</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heming</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Räuber</surname><given-names>S</given-names></name><name><surname>Mausberg</surname><given-names>AK</given-names></name><name><surname>Börsch</surname><given-names>AL</given-names></name><name><surname>Hartlehnert</surname><given-names>M</given-names></name><name><surname>Singhal</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>IN</given-names></name><name><surname>Fleischer</surname><given-names>M</given-names></name><name><surname>Szepanowski</surname><given-names>F</given-names></name><name><surname>Witzke</surname><given-names>O</given-names></name><name><surname>Brenner</surname><given-names>T</given-names></name><name><surname>Dittmer</surname><given-names>U</given-names></name><name><surname>Yosef</surname><given-names>N</given-names></name><name><surname>Kleinschnitz</surname><given-names>C</given-names></name><name><surname>Wiendl</surname><given-names>H</given-names></name><name><surname>Stettner</surname><given-names>M</given-names></name><name><surname>Meyer Zu Hörste</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid</article-title><source>Immunity</source><volume>54</volume><fpage>164</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.12.011</pub-id><pub-id pub-id-type="pmid">33382973</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Highton</surname><given-names>AJ</given-names></name><name><surname>Schuster</surname><given-names>IS</given-names></name><name><surname>Degli-Esposti</surname><given-names>MA</given-names></name><name><surname>Altfeld</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The role of natural killer cells in liver inflammation</article-title><source>Seminars in Immunopathology</source><volume>43</volume><fpage>519</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1007/s00281-021-00877-6</pub-id><pub-id pub-id-type="pmid">34230995</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>R</given-names></name><name><surname>Sarvnaz</surname><given-names>H</given-names></name><name><surname>Arabpour</surname><given-names>M</given-names></name><name><surname>Ramshe</surname><given-names>SM</given-names></name><name><surname>Asef-Kabiri</surname><given-names>L</given-names></name><name><surname>Yousefi</surname><given-names>H</given-names></name><name><surname>Akbari</surname><given-names>ME</given-names></name><name><surname>Eskandari</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy</article-title><source>Molecular Cancer</source><volume>21</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.1186/s12943-021-01492-7</pub-id><pub-id pub-id-type="pmid">35031075</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huffman</surname><given-names>JL</given-names></name><name><surname>Schenker</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Acute acalculous cholecystitis: a review</article-title><source>Clinical Gastroenterology and Hepatology</source><volume>8</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2009.08.034</pub-id><pub-id pub-id-type="pmid">19747982</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huster</surname><given-names>D</given-names></name><name><surname>Finegold</surname><given-names>MJ</given-names></name><name><surname>Morgan</surname><given-names>CT</given-names></name><name><surname>Burkhead</surname><given-names>JL</given-names></name><name><surname>Nixon</surname><given-names>R</given-names></name><name><surname>Vanderwerf</surname><given-names>SM</given-names></name><name><surname>Gilliam</surname><given-names>CT</given-names></name><name><surname>Lutsenko</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Consequences of copper accumulation in the livers of the Atp7b-/- (Wilson disease gene) knockout mice</article-title><source>The American Journal of Pathology</source><volume>168</volume><fpage>423</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2006.050312</pub-id><pub-id pub-id-type="pmid">16436657</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huster</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Structural and metabolic changes in Atp7b-/- mouse liver and potential for new interventions in Wilson’s disease</article-title><source>Annals of the New York Academy of Sciences</source><volume>1315</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1111/nyas.12337</pub-id><pub-id pub-id-type="pmid">24697742</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaeger</surname><given-names>N</given-names></name><name><surname>Gamini</surname><given-names>R</given-names></name><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Schettini</surname><given-names>JL</given-names></name><name><surname>Bugatti</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Rosadini</surname><given-names>CV</given-names></name><name><surname>Esaulova</surname><given-names>E</given-names></name><name><surname>Di Luccia</surname><given-names>B</given-names></name><name><surname>Kinnett</surname><given-names>B</given-names></name><name><surname>Vermi</surname><given-names>W</given-names></name><name><surname>Artyomov</surname><given-names>MN</given-names></name><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Jelinsky</surname><given-names>SA</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell analyses of crohn’s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>1921</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-22164-6</pub-id><pub-id pub-id-type="pmid">33771991</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Guerrero-Juarez</surname><given-names>CF</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>I</given-names></name><name><surname>Ramos</surname><given-names>R</given-names></name><name><surname>Kuan</surname><given-names>CH</given-names></name><name><surname>Myung</surname><given-names>P</given-names></name><name><surname>Plikus</surname><given-names>MV</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Inference and analysis of cell-cell communication using cellchat</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>1088</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21246-9</pub-id><pub-id pub-id-type="pmid">33597522</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knab</surname><given-names>LM</given-names></name><name><surname>Boller</surname><given-names>AM</given-names></name><name><surname>Mahvi</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cholecystitis</article-title><source>The Surgical Clinics of North America</source><volume>94</volume><fpage>455</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.suc.2014.01.005</pub-id><pub-id pub-id-type="pmid">24679431</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubes</surname><given-names>P</given-names></name><name><surname>Jenne</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Immune responses in the liver</article-title><source>Annual Review of Immunology</source><volume>36</volume><fpage>247</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-051116-052415</pub-id><pub-id pub-id-type="pmid">29328785</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurila</surname><given-names>JJ</given-names></name><name><surname>Ala-Kokko</surname><given-names>TI</given-names></name><name><surname>Laurila</surname><given-names>PA</given-names></name><name><surname>Saarnio</surname><given-names>J</given-names></name><name><surname>Koivukangas</surname><given-names>V</given-names></name><name><surname>Syrjälä</surname><given-names>H</given-names></name><name><surname>Karttunen</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Histopathology of acute acalculous cholecystitis in critically ill patients</article-title><source>Histopathology</source><volume>47</volume><fpage>485</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2559.2005.02238.x</pub-id><pub-id pub-id-type="pmid">16241996</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>H</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Dang</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell transcriptome profiling reveals vascular endothelial cell heterogeneity in human skin</article-title><source>Theranostics</source><volume>11</volume><fpage>6461</fpage><lpage>6476</lpage><pub-id pub-id-type="doi">10.7150/thno.54917</pub-id><pub-id pub-id-type="pmid">33995668</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Liao</surname><given-names>J</given-names></name><name><surname>Liao</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell analysis reveals immune landscape in kidneys of patients with chronic transplant rejection</article-title><source>Theranostics</source><volume>10</volume><fpage>8851</fpage><lpage>8862</lpage><pub-id pub-id-type="doi">10.7150/thno.48201</pub-id><pub-id pub-id-type="pmid">32754283</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Xian</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis</article-title><source>Cancer Immunology, Immunotherapy</source><volume>71</volume><fpage>277</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1007/s00262-021-02978-5</pub-id><pub-id pub-id-type="pmid">34129052</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zuo</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Jing</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance</article-title><source>Cancer Cell</source><volume>41</volume><fpage>272</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2023.01.001</pub-id><pub-id pub-id-type="pmid">36706761</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loozen</surname><given-names>CS</given-names></name><name><surname>Oor</surname><given-names>JE</given-names></name><name><surname>van Ramshorst</surname><given-names>B</given-names></name><name><surname>van Santvoort</surname><given-names>HC</given-names></name><name><surname>Boerma</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Conservative treatment of acute cholecystitis: a systematic review and pooled analysis</article-title><source>Surgical Endoscopy</source><volume>31</volume><fpage>504</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1007/s00464-016-5011-x</pub-id><pub-id pub-id-type="pmid">27317033</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luoma</surname><given-names>AM</given-names></name><name><surname>Suo</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>HL</given-names></name><name><surname>Sharova</surname><given-names>T</given-names></name><name><surname>Sullivan</surname><given-names>K</given-names></name><name><surname>Manos</surname><given-names>M</given-names></name><name><surname>Bowling</surname><given-names>P</given-names></name><name><surname>Hodi</surname><given-names>FS</given-names></name><name><surname>Rahma</surname><given-names>O</given-names></name><name><surname>Sullivan</surname><given-names>RJ</given-names></name><name><surname>Boland</surname><given-names>GM</given-names></name><name><surname>Nowak</surname><given-names>JA</given-names></name><name><surname>Dougan</surname><given-names>SK</given-names></name><name><surname>Dougan</surname><given-names>M</given-names></name><name><surname>Yuan</surname><given-names>GC</given-names></name><name><surname>Wucherpfennig</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular pathways of colon inflammation induced by cancer immunotherapy</article-title><source>Cell</source><volume>182</volume><fpage>655</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.06.001</pub-id><pub-id pub-id-type="pmid">32603654</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madissoon</surname><given-names>E</given-names></name><name><surname>Wilbrey-Clark</surname><given-names>A</given-names></name><name><surname>Miragaia</surname><given-names>RJ</given-names></name><name><surname>Saeb-Parsy</surname><given-names>K</given-names></name><name><surname>Mahbubani</surname><given-names>KT</given-names></name><name><surname>Georgakopoulos</surname><given-names>N</given-names></name><name><surname>Harding</surname><given-names>P</given-names></name><name><surname>Polanski</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Nowicki-Osuch</surname><given-names>K</given-names></name><name><surname>Fitzgerald</surname><given-names>RC</given-names></name><name><surname>Loudon</surname><given-names>KW</given-names></name><name><surname>Ferdinand</surname><given-names>JR</given-names></name><name><surname>Clatworthy</surname><given-names>MR</given-names></name><name><surname>Tsingene</surname><given-names>A</given-names></name><name><surname>van Dongen</surname><given-names>S</given-names></name><name><surname>Dabrowska</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Stubbington</surname><given-names>MJT</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Stegle</surname><given-names>O</given-names></name><name><surname>Meyer</surname><given-names>KB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation</article-title><source>Genome Biology</source><volume>21</volume><elocation-id>1</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-019-1906-x</pub-id><pub-id pub-id-type="pmid">31892341</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markaki</surname><given-names>I</given-names></name><name><surname>Konsoula</surname><given-names>A</given-names></name><name><surname>Markaki</surname><given-names>L</given-names></name><name><surname>Spernovasilis</surname><given-names>N</given-names></name><name><surname>Papadakis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Acute acalculous cholecystitis due to infectious causes</article-title><source>World Journal of Clinical Cases</source><volume>9</volume><fpage>6674</fpage><lpage>6685</lpage><pub-id pub-id-type="doi">10.12998/wjcc.v9.i23.6674</pub-id><pub-id pub-id-type="pmid">34447814</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matyas</surname><given-names>C</given-names></name><name><surname>Haskó</surname><given-names>G</given-names></name><name><surname>Liaudet</surname><given-names>L</given-names></name><name><surname>Trojnar</surname><given-names>E</given-names></name><name><surname>Pacher</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications</article-title><source>Nature Reviews. Cardiology</source><volume>18</volume><fpage>117</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/s41569-020-0433-5</pub-id><pub-id pub-id-type="pmid">32999450</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinney</surname><given-names>EF</given-names></name><name><surname>Lyons</surname><given-names>PA</given-names></name><name><surname>Carr</surname><given-names>EJ</given-names></name><name><surname>Hollis</surname><given-names>JL</given-names></name><name><surname>Jayne</surname><given-names>DRW</given-names></name><name><surname>Willcocks</surname><given-names>LC</given-names></name><name><surname>Koukoulaki</surname><given-names>M</given-names></name><name><surname>Brazma</surname><given-names>A</given-names></name><name><surname>Jovanovic</surname><given-names>V</given-names></name><name><surname>Kemeny</surname><given-names>DM</given-names></name><name><surname>Pollard</surname><given-names>AJ</given-names></name><name><surname>Macary</surname><given-names>PA</given-names></name><name><surname>Chaudhry</surname><given-names>AN</given-names></name><name><surname>Smith</surname><given-names>KGC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A CD8+ T cell transcription signature predicts prognosis in autoimmune disease</article-title><source>Nature Medicine</source><volume>16</volume><fpage>586</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1038/nm.2130</pub-id><pub-id pub-id-type="pmid">20400961</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinney</surname><given-names>EF</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Jayne</surname><given-names>DRW</given-names></name><name><surname>Lyons</surname><given-names>PA</given-names></name><name><surname>Smith</surname><given-names>KGC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection</article-title><source>Nature</source><volume>523</volume><fpage>612</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1038/nature14468</pub-id><pub-id pub-id-type="pmid">26123020</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medici</surname><given-names>V</given-names></name><name><surname>Shibata</surname><given-names>NM</given-names></name><name><surname>Kharbanda</surname><given-names>KK</given-names></name><name><surname>LaSalle</surname><given-names>JM</given-names></name><name><surname>Woods</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Engelberg</surname><given-names>JA</given-names></name><name><surname>Devaraj</surname><given-names>S</given-names></name><name><surname>Török</surname><given-names>NJ</given-names></name><name><surname>Jiang</surname><given-names>JX</given-names></name><name><surname>Havel</surname><given-names>PJ</given-names></name><name><surname>Lönnerdal</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Halsted</surname><given-names>CH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Wilson’s disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease</article-title><source>Hepatology</source><volume>57</volume><fpage>555</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1002/hep.26047</pub-id><pub-id pub-id-type="pmid">22945834</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muchenditsi</surname><given-names>A</given-names></name><name><surname>Talbot</surname><given-names>CC</given-names><suffix>Jr</suffix></name><name><surname>Gottlieb</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>B</given-names></name><name><surname>Boronina</surname><given-names>T</given-names></name><name><surname>Cole</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Dev</surname><given-names>S</given-names></name><name><surname>Hamilton</surname><given-names>JP</given-names></name><name><surname>Lutsenko</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Systemic deletion of Atp7b modifies the hepatocytes’ response to copper overload in the mouse models of wilson disease</article-title><source>Scientific Reports</source><volume>11</volume><elocation-id>5659</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-84894-3</pub-id><pub-id pub-id-type="pmid">33707579</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>KL</given-names></name><name><surname>Finlay</surname><given-names>DK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Immunometabolism and natural killer cell responses</article-title><source>Nature Reviews. Immunology</source><volume>19</volume><fpage>282</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0139-2</pub-id><pub-id pub-id-type="pmid">30808985</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parisi</surname><given-names>L</given-names></name><name><surname>Bassani</surname><given-names>B</given-names></name><name><surname>Tremolati</surname><given-names>M</given-names></name><name><surname>Gini</surname><given-names>E</given-names></name><name><surname>Farronato</surname><given-names>G</given-names></name><name><surname>Bruno</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Natural killer cells in the orchestration of chronic inflammatory diseases</article-title><source>Journal of Immunology Research</source><volume>2017</volume><elocation-id>4218254</elocation-id><pub-id pub-id-type="doi">10.1155/2017/4218254</pub-id><pub-id pub-id-type="pmid">28428965</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Hsueh</surname><given-names>PC</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Ho</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Microenvironment-driven metabolic adaptations guiding CD8<sup>+</sup> T cell anti-tumor immunity</article-title><source>Immunity</source><volume>56</volume><fpage>32</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2022.12.008</pub-id><pub-id pub-id-type="pmid">36630916</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pombo Antunes</surname><given-names>AR</given-names></name><name><surname>Scheyltjens</surname><given-names>I</given-names></name><name><surname>Lodi</surname><given-names>F</given-names></name><name><surname>Messiaen</surname><given-names>J</given-names></name><name><surname>Antoranz</surname><given-names>A</given-names></name><name><surname>Duerinck</surname><given-names>J</given-names></name><name><surname>Kancheva</surname><given-names>D</given-names></name><name><surname>Martens</surname><given-names>L</given-names></name><name><surname>De Vlaminck</surname><given-names>K</given-names></name><name><surname>Van Hove</surname><given-names>H</given-names></name><name><surname>Kjølner Hansen</surname><given-names>SS</given-names></name><name><surname>Bosisio</surname><given-names>FM</given-names></name><name><surname>Van der Borght</surname><given-names>K</given-names></name><name><surname>De Vleeschouwer</surname><given-names>S</given-names></name><name><surname>Sciot</surname><given-names>R</given-names></name><name><surname>Bouwens</surname><given-names>L</given-names></name><name><surname>Verfaillie</surname><given-names>M</given-names></name><name><surname>Vandamme</surname><given-names>N</given-names></name><name><surname>Vandenbroucke</surname><given-names>RE</given-names></name><name><surname>De Wever</surname><given-names>O</given-names></name><name><surname>Saeys</surname><given-names>Y</given-names></name><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Gysemans</surname><given-names>C</given-names></name><name><surname>Neyns</surname><given-names>B</given-names></name><name><surname>De Smet</surname><given-names>F</given-names></name><name><surname>Lambrechts</surname><given-names>D</given-names></name><name><surname>Van Ginderachter</surname><given-names>JA</given-names></name><name><surname>Movahedi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization</article-title><source>Nature Neuroscience</source><volume>24</volume><fpage>595</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-00789-y</pub-id><pub-id pub-id-type="pmid">33782623</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popescu</surname><given-names>D-M</given-names></name><name><surname>Botting</surname><given-names>RA</given-names></name><name><surname>Stephenson</surname><given-names>E</given-names></name><name><surname>Green</surname><given-names>K</given-names></name><name><surname>Webb</surname><given-names>S</given-names></name><name><surname>Jardine</surname><given-names>L</given-names></name><name><surname>Calderbank</surname><given-names>EF</given-names></name><name><surname>Polanski</surname><given-names>K</given-names></name><name><surname>Goh</surname><given-names>I</given-names></name><name><surname>Efremova</surname><given-names>M</given-names></name><name><surname>Acres</surname><given-names>M</given-names></name><name><surname>Maunder</surname><given-names>D</given-names></name><name><surname>Vegh</surname><given-names>P</given-names></name><name><surname>Gitton</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>J-E</given-names></name><name><surname>Vento-Tormo</surname><given-names>R</given-names></name><name><surname>Miao</surname><given-names>Z</given-names></name><name><surname>Dixon</surname><given-names>D</given-names></name><name><surname>Rowell</surname><given-names>R</given-names></name><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Fletcher</surname><given-names>J</given-names></name><name><surname>Poyner</surname><given-names>E</given-names></name><name><surname>Reynolds</surname><given-names>G</given-names></name><name><surname>Mather</surname><given-names>M</given-names></name><name><surname>Moldovan</surname><given-names>C</given-names></name><name><surname>Mamanova</surname><given-names>L</given-names></name><name><surname>Greig</surname><given-names>F</given-names></name><name><surname>Young</surname><given-names>MD</given-names></name><name><surname>Meyer</surname><given-names>KB</given-names></name><name><surname>Lisgo</surname><given-names>S</given-names></name><name><surname>Bacardit</surname><given-names>J</given-names></name><name><surname>Fuller</surname><given-names>A</given-names></name><name><surname>Millar</surname><given-names>B</given-names></name><name><surname>Innes</surname><given-names>B</given-names></name><name><surname>Lindsay</surname><given-names>S</given-names></name><name><surname>Stubbington</surname><given-names>MJT</given-names></name><name><surname>Kowalczyk</surname><given-names>MS</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Ashenberg</surname><given-names>O</given-names></name><name><surname>Tabaka</surname><given-names>M</given-names></name><name><surname>Dionne</surname><given-names>D</given-names></name><name><surname>Tickle</surname><given-names>TL</given-names></name><name><surname>Slyper</surname><given-names>M</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Filby</surname><given-names>A</given-names></name><name><surname>Carey</surname><given-names>P</given-names></name><name><surname>Villani</surname><given-names>A-C</given-names></name><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Chédotal</surname><given-names>A</given-names></name><name><surname>Roberts</surname><given-names>I</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Behjati</surname><given-names>S</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Decoding human fetal liver haematopoiesis</article-title><source>Nature</source><volume>574</volume><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1652-y</pub-id><pub-id pub-id-type="pmid">31597962</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poznanski</surname><given-names>SM</given-names></name><name><surname>Ashkar</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>What defines NK cell functional fate: phenotype or metabolism?</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>1414</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.01414</pub-id><pub-id pub-id-type="pmid">31275330</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Hill</surname><given-names>A</given-names></name><name><surname>Packer</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>YA</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-cell mRNA quantification and differential analysis with census</article-title><source>Nature Methods</source><volume>14</volume><fpage>309</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4150</pub-id><pub-id pub-id-type="pmid">28114287</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Racanelli</surname><given-names>V</given-names></name><name><surname>Rehermann</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The liver as an immunological organ</article-title><source>Hepatology</source><volume>43</volume><fpage>S54</fpage><lpage>S62</lpage><pub-id pub-id-type="doi">10.1002/hep.21060</pub-id><pub-id pub-id-type="pmid">16447271</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>P</given-names></name><name><surname>Dobie</surname><given-names>R</given-names></name><name><surname>Wilson-Kanamori</surname><given-names>JR</given-names></name><name><surname>Dora</surname><given-names>EF</given-names></name><name><surname>Henderson</surname><given-names>BEP</given-names></name><name><surname>Luu</surname><given-names>NT</given-names></name><name><surname>Portman</surname><given-names>JR</given-names></name><name><surname>Matchett</surname><given-names>KP</given-names></name><name><surname>Brice</surname><given-names>M</given-names></name><name><surname>Marwick</surname><given-names>JA</given-names></name><name><surname>Taylor</surname><given-names>RS</given-names></name><name><surname>Efremova</surname><given-names>M</given-names></name><name><surname>Vento-Tormo</surname><given-names>R</given-names></name><name><surname>Carragher</surname><given-names>NO</given-names></name><name><surname>Kendall</surname><given-names>TJ</given-names></name><name><surname>Fallowfield</surname><given-names>JA</given-names></name><name><surname>Harrison</surname><given-names>EM</given-names></name><name><surname>Mole</surname><given-names>DJ</given-names></name><name><surname>Wigmore</surname><given-names>SJ</given-names></name><name><surname>Newsome</surname><given-names>PN</given-names></name><name><surname>Weston</surname><given-names>CJ</given-names></name><name><surname>Iredale</surname><given-names>JP</given-names></name><name><surname>Tacke</surname><given-names>F</given-names></name><name><surname>Pollard</surname><given-names>JW</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Marioni</surname><given-names>JC</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Henderson</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Resolving the fibrotic niche of human liver cirrhosis at single-cell level</article-title><source>Nature</source><volume>575</volume><fpage>512</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1631-3</pub-id><pub-id pub-id-type="pmid">31597160</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riera-Domingo</surname><given-names>C</given-names></name><name><surname>Audigé</surname><given-names>A</given-names></name><name><surname>Granja</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>WC</given-names></name><name><surname>Ho</surname><given-names>PC</given-names></name><name><surname>Baltazar</surname><given-names>F</given-names></name><name><surname>Stockmann</surname><given-names>C</given-names></name><name><surname>Mazzone</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Immunity, hypoxia, and metabolism-the ménage à trois of cancer: implications for immunotherapy</article-title><source>Physiological Reviews</source><volume>100</volume><fpage>1</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1152/physrev.00018.2019</pub-id><pub-id pub-id-type="pmid">31414610</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>EA</given-names></name><name><surname>Robinson</surname><given-names>BH</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mitochondrial structure and function in the untreated Jackson toxic milk (tx-j) mouse, a model for wilson disease</article-title><source>Molecular Genetics and Metabolism</source><volume>93</volume><fpage>54</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2007.08.127</pub-id><pub-id pub-id-type="pmid">17981064</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathe</surname><given-names>A</given-names></name><name><surname>Grimes</surname><given-names>SM</given-names></name><name><surname>Lau</surname><given-names>BT</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Suarez</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>RJ</given-names></name><name><surname>Poultsides</surname><given-names>G</given-names></name><name><surname>Ji</surname><given-names>HP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment</article-title><source>Clinical Cancer Research</source><volume>26</volume><fpage>2640</fpage><lpage>2653</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-19-3231</pub-id><pub-id pub-id-type="pmid">32060101</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shevtsov</surname><given-names>M</given-names></name><name><surname>Multhoff</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Heat shock protein-peptide and hsp-based immunotherapies for the treatment of cancer</article-title><source>Frontiers in Immunology</source><volume>7</volume><elocation-id>171</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2016.00171</pub-id><pub-id pub-id-type="pmid">27199993</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Al-Eryani</surname><given-names>G</given-names></name><name><surname>Carswell</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>JM</given-names></name><name><surname>Blackburn</surname><given-names>J</given-names></name><name><surname>Barton</surname><given-names>K</given-names></name><name><surname>Roden</surname><given-names>D</given-names></name><name><surname>Luciani</surname><given-names>F</given-names></name><name><surname>Giang Phan</surname><given-names>T</given-names></name><name><surname>Junankar</surname><given-names>S</given-names></name><name><surname>Jackson</surname><given-names>K</given-names></name><name><surname>Goodnow</surname><given-names>CC</given-names></name><name><surname>Smith</surname><given-names>MA</given-names></name><name><surname>Swarbrick</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>3120</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-11049-4</pub-id><pub-id pub-id-type="pmid">31311926</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>O</given-names></name><name><surname>Dunbar</surname><given-names>PR</given-names></name><name><surname>Bartlett</surname><given-names>A</given-names></name><name><surname>Phillips</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver--a systematic review</article-title><source>Journal of Hepatology</source><volume>62</volume><fpage>458</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2014.10.006</pub-id><pub-id pub-id-type="pmid">25315649</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma</article-title><source>Cellular &amp; Molecular Immunology</source><volume>12</volume><fpage>292</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1038/cmi.2014.91</pub-id><pub-id pub-id-type="pmid">25308752</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Wen</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Xiao</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer</article-title><source>Oncoimmunology</source><volume>6</volume><elocation-id>e1264562</elocation-id><pub-id pub-id-type="doi">10.1080/2162402X.2016.1264562</pub-id><pub-id pub-id-type="pmid">28197391</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Wen</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>R</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Xiao</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Human CD96 correlates to natural killer cell exhaustion and predicts the prognosis of human hepatocellular carcinoma</article-title><source>Hepatology</source><volume>70</volume><fpage>168</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1002/hep.30347</pub-id><pub-id pub-id-type="pmid">30411378</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Zhong</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Volpe</surname><given-names>G</given-names></name><name><surname>Qiu</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Ward</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Esteban</surname><given-names>MA</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Dean</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma</article-title><source>Cell</source><volume>184</volume><fpage>404</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.11.041</pub-id><pub-id pub-id-type="pmid">33357445</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The roles of neutrophils in the pathogenesis of liver diseases</article-title><source>Frontiers in Immunology</source><volume>12</volume><elocation-id>625472</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.625472</pub-id><pub-id pub-id-type="pmid">33763069</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tirosh</surname><given-names>I</given-names></name><name><surname>Izar</surname><given-names>B</given-names></name><name><surname>Prakadan</surname><given-names>SM</given-names></name><name><surname>Wadsworth</surname><given-names>MH</given-names></name><name><surname>Treacy</surname><given-names>D</given-names></name><name><surname>Trombetta</surname><given-names>JJ</given-names></name><name><surname>Rotem</surname><given-names>A</given-names></name><name><surname>Rodman</surname><given-names>C</given-names></name><name><surname>Lian</surname><given-names>C</given-names></name><name><surname>Murphy</surname><given-names>G</given-names></name><name><surname>Fallahi-Sichani</surname><given-names>M</given-names></name><name><surname>Dutton-Regester</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>JR</given-names></name><name><surname>Cohen</surname><given-names>O</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>Lu</surname><given-names>D</given-names></name><name><surname>Genshaft</surname><given-names>AS</given-names></name><name><surname>Hughes</surname><given-names>TK</given-names></name><name><surname>Ziegler</surname><given-names>CGK</given-names></name><name><surname>Kazer</surname><given-names>SW</given-names></name><name><surname>Gaillard</surname><given-names>A</given-names></name><name><surname>Kolb</surname><given-names>KE</given-names></name><name><surname>Villani</surname><given-names>AC</given-names></name><name><surname>Johannessen</surname><given-names>CM</given-names></name><name><surname>Andreev</surname><given-names>AY</given-names></name><name><surname>Van Allen</surname><given-names>EM</given-names></name><name><surname>Bertagnolli</surname><given-names>M</given-names></name><name><surname>Sorger</surname><given-names>PK</given-names></name><name><surname>Sullivan</surname><given-names>RJ</given-names></name><name><surname>Flaherty</surname><given-names>KT</given-names></name><name><surname>Frederick</surname><given-names>DT</given-names></name><name><surname>Jané-Valbuena</surname><given-names>J</given-names></name><name><surname>Yoon</surname><given-names>CH</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Garraway</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq</article-title><source>Science</source><volume>352</volume><fpage>189</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1126/science.aad0501</pub-id><pub-id pub-id-type="pmid">27124452</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van de Sande</surname><given-names>B</given-names></name><name><surname>Flerin</surname><given-names>C</given-names></name><name><surname>Davie</surname><given-names>K</given-names></name><name><surname>De Waegeneer</surname><given-names>M</given-names></name><name><surname>Hulselmans</surname><given-names>G</given-names></name><name><surname>Aibar</surname><given-names>S</given-names></name><name><surname>Seurinck</surname><given-names>R</given-names></name><name><surname>Saelens</surname><given-names>W</given-names></name><name><surname>Cannoodt</surname><given-names>R</given-names></name><name><surname>Rouchon</surname><given-names>Q</given-names></name><name><surname>Verbeiren</surname><given-names>T</given-names></name><name><surname>De Maeyer</surname><given-names>D</given-names></name><name><surname>Reumers</surname><given-names>J</given-names></name><name><surname>Saeys</surname><given-names>Y</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A scalable SCENIC workflow for single-cell gene regulatory network analysis</article-title><source>Nature Protocols</source><volume>15</volume><fpage>2247</fpage><lpage>2276</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-0336-2</pub-id><pub-id pub-id-type="pmid">32561888</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Dijk</surname><given-names>AH</given-names></name><name><surname>de Reuver</surname><given-names>PR</given-names></name><name><surname>Tasma</surname><given-names>TN</given-names></name><name><surname>van Dieren</surname><given-names>S</given-names></name><name><surname>Hugh</surname><given-names>TJ</given-names></name><name><surname>Boermeester</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Systematic review of antibiotic treatment for acute calculous cholecystitis</article-title><source>The British Journal of Surgery</source><volume>103</volume><fpage>797</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1002/bjs.10146</pub-id><pub-id pub-id-type="pmid">27027851</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Jing</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>S100A8/A9 in Inflammation</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>1298</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01298</pub-id><pub-id pub-id-type="pmid">29942307</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>You</surname><given-names>X</given-names></name><name><surname>Yi</surname><given-names>T</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Zou</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma</article-title><source>Signal Transduction and Targeted Therapy</source><volume>5</volume><elocation-id>196</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-020-00248-x</pub-id><pub-id pub-id-type="pmid">32973147</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Nie</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Xian</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Chai</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Tong</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>L</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>ZG</given-names></name><name><surname>Yi</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Delfouneso</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Nutt</surname><given-names>SL</given-names></name><name><surname>Lew</surname><given-names>AM</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Wen</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia</article-title><source>Cell</source><volume>183</volume><fpage>1867</fpage><lpage>1883</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.10.048</pub-id><pub-id pub-id-type="pmid">33248023</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>YC</given-names></name><name><surname>Xu</surname><given-names>ZR</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2020">2020c</year><article-title>Comparative analysis of cell lineage differentiation during hepatogenesis in humans and mice at the single-cell transcriptome level</article-title><source>Cell Research</source><volume>30</volume><fpage>1109</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1038/s41422-020-0378-6</pub-id><pub-id pub-id-type="pmid">32690901</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020d</year><article-title>Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function</article-title><source>Nature Cell Biology</source><volume>22</volume><fpage>108</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1038/s41556-019-0446-7</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>M</given-names></name><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Zong</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>A</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma</article-title><source>Cell Discovery</source><volume>8</volume><elocation-id>101</elocation-id><pub-id pub-id-type="doi">10.1038/s41421-022-00445-8</pub-id><pub-id pub-id-type="pmid">36198671</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>DW</given-names></name><name><surname>Greenwell-Wild</surname><given-names>T</given-names></name><name><surname>Brenchley</surname><given-names>L</given-names></name><name><surname>Dutzan</surname><given-names>N</given-names></name><name><surname>Overmiller</surname><given-names>A</given-names></name><name><surname>Sawaya</surname><given-names>AP</given-names></name><name><surname>Webb</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>D</given-names></name><collab>NIDCD/NIDCR Genomics and Computational Biology Core</collab><name><surname>Hajishengallis</surname><given-names>G</given-names></name><name><surname>Divaris</surname><given-names>K</given-names></name><name><surname>Morasso</surname><given-names>M</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name><name><surname>Moutsopoulos</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Human oral mucosa cell atlas reveals a stromal-neutrophil axis regulating tissue immunity</article-title><source>Cell</source><volume>184</volume><fpage>4090</fpage><lpage>4104</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.05.013</pub-id><pub-id pub-id-type="pmid">34129837</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wouters</surname><given-names>MCA</given-names></name><name><surname>Nelson</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer</article-title><source>Clinical Cancer Research</source><volume>24</volume><fpage>6125</fpage><lpage>6135</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-18-1481</pub-id><pub-id pub-id-type="pmid">30049748</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>SY</given-names></name><name><surname>Fu</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>YZ</given-names></name><name><surname>Shao</surname><given-names>ZM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Natural killer cells in cancer biology and therapy</article-title><source>Molecular Cancer</source><volume>19</volume><elocation-id>120</elocation-id><pub-id pub-id-type="doi">10.1186/s12943-020-01238-x</pub-id><pub-id pub-id-type="pmid">32762681</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Qiao</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Ren</surname><given-names>S</given-names></name><name><surname>Odenthal</surname><given-names>M</given-names></name><name><surname>Buettner</surname><given-names>R</given-names></name><name><surname>Fang</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>2540</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-22801-0</pub-id><pub-id pub-id-type="pmid">33953163</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xin</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Hao</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Chai</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The immune landscape of human thymic epithelial tumors</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>5463</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-33170-7</pub-id><pub-id pub-id-type="pmid">36115836</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>L-Y</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Lou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Liang</surname><given-names>T</given-names></name><name><surname>Schamel</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>Z-J</given-names></name><name><surname>Song</surname><given-names>B-L</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity</article-title><source>Cancer Cell</source><volume>41</volume><fpage>1276</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2023.04.016</pub-id><pub-id pub-id-type="pmid">37244259</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>GM</given-names></name><name><surname>Wang</surname><given-names>RM</given-names></name><name><surname>Xia</surname><given-names>N</given-names></name><name><surname>Zheng</surname><given-names>ZW</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>ZY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Prevalent pathogenic variants of <italic>ATP7B</italic> in chinese patients with wilson’s disease: geographical distribution and founder effect</article-title><source>Genes</source><volume>12</volume><elocation-id>336</elocation-id><pub-id pub-id-type="doi">10.3390/genes12030336</pub-id><pub-id pub-id-type="pmid">33668890</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>GC</given-names></name><name><surname>Wang</surname><given-names>LG</given-names></name><name><surname>Han</surname><given-names>YY</given-names></name><name><surname>He</surname><given-names>QY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title><source>OMICS</source><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>Z</given-names></name><name><surname>Hou</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Bian</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Ni</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Bian</surname><given-names>L</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell RNA sequencing resolves spatiotemporal development of pre-thymic lymphoid progenitors and thymus organogenesis in human embryos</article-title><source>Immunity</source><volume>51</volume><fpage>930</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.09.008</pub-id><pub-id pub-id-type="pmid">31604687</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>L</given-names></name><name><surname>Kong</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wan</surname><given-names>YJY</given-names></name><name><surname>Duan</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>YP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Persistence of cirrhosis is maintained by intrahepatic regulatory T cells that inhibit fibrosis resolution by regulating the balance of tissue inhibitors of metalloproteinases and matrix metalloproteinases</article-title><source>Translational Research</source><volume>169</volume><fpage>67</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2015.10.008</pub-id><pub-id pub-id-type="pmid">26613891</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Bi</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity</article-title><source>Nature Immunology</source><volume>19</volume><fpage>723</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0132-0</pub-id><pub-id pub-id-type="pmid">29915296</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>N</given-names></name><name><surname>Patel</surname><given-names>SJ</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>R</given-names></name><name><surname>Modak</surname><given-names>M</given-names></name><name><surname>Carotta</surname><given-names>S</given-names></name><name><surname>Haslinger</surname><given-names>C</given-names></name><name><surname>Kind</surname><given-names>D</given-names></name><name><surname>Peet</surname><given-names>GW</given-names></name><name><surname>Zhong</surname><given-names>G</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>M</given-names></name><name><surname>Bergmann</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Kerkar</surname><given-names>SP</given-names></name><name><surname>Vogt</surname><given-names>AB</given-names></name><name><surname>Pflanz</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Landscape and dynamics of single immune cells in hepatocellular carcinoma</article-title><source>Cell</source><volume>179</volume><fpage>829</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.10.003</pub-id><pub-id pub-id-type="pmid">31675496</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>XM</given-names></name><name><surname>Li</surname><given-names>SR</given-names></name><name><surname>Twelkmeyer</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>WH</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><name><surname>Wang</surname><given-names>SF</given-names></name><name><surname>Chen</surname><given-names>JZ</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>YZ</given-names></name><name><surname>Chen</surname><given-names>XW</given-names></name><name><surname>Wang</surname><given-names>SD</given-names></name><name><surname>Niu</surname><given-names>JQ</given-names></name><name><surname>Chen</surname><given-names>HR</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>NKG2A is a NK cell exhaustion checkpoint for HCV persistence</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1507</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09212-y</pub-id><pub-id pub-id-type="pmid">30944315</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Gan</surname><given-names>R</given-names></name><name><surname>Zhen</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals</article-title><source>Signal Transduction and Targeted Therapy</source><volume>5</volume><elocation-id>156</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-020-00263-y</pub-id><pub-id pub-id-type="pmid">32796814</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Rousseaux</surname><given-names>N</given-names></name><name><surname>Walzer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Eomes and T-bet, a dynamic duo regulating NK cell differentiation</article-title><source>BioEssays</source><volume>44</volume><elocation-id>e2100281</elocation-id><pub-id pub-id-type="doi">10.1002/bies.202100281</pub-id><pub-id pub-id-type="pmid">35023197</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Cui</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Hua</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>M</given-names></name><name><surname>Liao</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cell diversity and immune infiltration in the parathyroid tumour microenvironment</article-title><source>Endocrine-Related Cancer</source><volume>30</volume><elocation-id>e220325</elocation-id><pub-id pub-id-type="doi">10.1530/ERC-22-0325</pub-id><pub-id pub-id-type="pmid">36602147</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Qu</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human</article-title><source>Cell Discovery</source><volume>6</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.1038/s41421-020-0157-z</pub-id><pub-id pub-id-type="pmid">32351704</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zischka</surname><given-names>H</given-names></name><name><surname>Lichtmannegger</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pathological mitochondrial copper overload in livers of Wilson’s disease patients and related animal models</article-title><source>Annals of the New York Academy of Sciences</source><volume>1315</volume><fpage>6</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1111/nyas.12347</pub-id><pub-id pub-id-type="pmid">24517326</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98867.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nair</surname><given-names>Shiny</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Yale University</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>This study presents <bold>valuable</bold> findings, based on <bold>solid</bold> methods, to link metabolic dysfunction in Wilson's disease to immune cell dysregulation and poor cholecystitis outcomes. The integration of clinical data and single-cell analyses highlights NK cell exhaustion as a key factor, offering insights with potential therapeutic implications. The work will be of interest to colleagues in inflammatory and metabolic diseases.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98867.3.sa1</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Wilson's disease is a rare genetic disorder caused by mutations in the ATP7B gene. Previous studies have documented that ATP7B mutations can disrupt copper metabolism, affecting brain and liver function. In this paper, the authors performed a retrospective clinical study and found that Wilson's disease has a high incidence of cholecystitis. Single-cell RNA-seq analysis revealed changes in the immune microenvironment, including the activation of immune responses and the exhaustion of natural killer cells.</p><p>Strengths:</p><p>A key finding of this study is that the predominant ATP7B gene mutation in the Chinese population is the 2333G&gt;T (p. R778L) mutation. The authors reported associations between Wilson's disease and cholecystitis, as well as the exhaustion of natural killer cells.</p><p>Weaknesses:</p><p>The underlying mechanisms linking ATP7B mutations to cholecystitis and natural killer cell exhaustion remain unclear. Specifically, it is not yet determined whether copper metabolism alterations directly cause cholecystitis and natural killer cell exhaustion, or if these effects are secondary to liver dysfunction.</p><p>Comments on revisions:</p><p>The authors fully addressed my questions and I don't have further comments.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98867.3.sa2</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jin</surname><given-names>Yong</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of USTC</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xing</surname><given-names>Jiayu</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of USTC</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Dai</surname><given-names>Chenyu</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Anhui University of Chinese Medicine</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Jin</surname><given-names>Lei</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Anhui University of Chinese Medicine</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wanying</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of USTC</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Tao</surname><given-names>Qianqian</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Anhui University of Chinese Medicine</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Hou</surname><given-names>Mei</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of USTC</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Ziyi</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Anhui University of Chinese Medicine</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Wen</given-names></name><role specific-use="author">Author</role><aff><institution>Second Military Medical University</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Qiyu</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of USTC</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Hongyang</given-names></name><role specific-use="author">Author</role><aff><institution>Second Military Medical University</institution><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Qingsheng</given-names></name><role specific-use="author">Author</role><aff><institution>The First Affiliated Hospital of Anhui University of Chinese Medicine</institution><addr-line><named-content content-type="city">Hefei</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>Wilson's Disease (WD) is an inherited rare pathological condition due to a mutation in ATP7B that alters mitochondrial structure and dysfunction. Additionally, WD results in dysregulated copper metabolism in patients. These metabolic abnormalities affect the functions of the liver and can result in cholecystitis. Understanding the immune component and its contribution to WD and cholecystitis has been challenging. In this work, the authors have performed single-cell RNA sequencing of mesenchymal tissue from three WD patients and three liver hemangioma patients.</p><p>Strengths:</p><p>The authors describe the transcriptomic alterations in myeloid and lymphoid compartments.</p><p>Weaknesses:</p><p>In brief, this manuscript lacks a clear focus, and the writing needs vast improvement. Figures lack details (or are misrepresented), the results section only catalogs observations, and the discussion needs to focus on their findings' mechanistic and functional relevance. The major weakness of this manuscript is that the authors do not provide a mechanistic link between the absence of ATP7B and NK cells' impaired/altered functions. While the work is of high clinical relevance, there are various areas that could be improved.</p></disp-quote><p>In this study, we reported for the first time that <italic>ATP7B</italic> mutation and the resulting metabolic abnormalities in hepatocytes cause functional alteration of immune cells in WD patients. We dissected the transcriptional profiles of liver mesenchymal cells and delineated the functional differences of main immune cells in WD patients through scRNA-seq. The NK cell exhaustion and its clinical significance were further demonstrated.</p><p>The mechanism study is of our concern. Given that the <italic>ATP7B</italic> mutation is hepatocyte-specific, its effect on immune cells is most probably through intercellular communication rather than through the direct action of ATP7B protein. How <italic>ATP7B</italic> mutation disturbs the metabolic homeostasis in hepatocyte, how metabolic pathways regulate the release of signal substances, and how signal substances act on the NK cells need to be explained. These contents, together with this manuscript, are beyond the scope of a single article, so we put the novelty in this manuscript.</p><p>We sincerely appreciate the comments. We have improved the manuscript based on your valuable suggestions. The mechanism study is our subsequent research topic. We are actively promoting it and have found that <italic>ATP7B</italic> mutation rewires a certain metabolism pathway in hepatocyte, and that a critical metabolite functions as the mediator causing NK cell exhaustion.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>Wilson's disease is a rare genetic disorder caused by mutations in the ATP7B gene. Previous studies have documented that ATP7B mutations can disrupt copper metabolism, affecting brain and liver function. In this paper, the authors performed a retrospective clinical study and found that Wilson's disease has a high incidence of cholecystitis. Single-cell RNA-seq analysis revealed changes in the immune microenvironment, including the activation of immune responses and the exhaustion of natural killer cells.</p><p>Strengths:</p><p>A key finding of this study is that the predominant ATP7B gene mutation in the Chinese population is the 2333G&gt;T (p. R778L) mutation. The authors reported associations between Wilson's disease and cholecystitis, as well as the exhaustion of natural killer cells.</p><p>Weaknesses:</p></disp-quote><p>The underlying mechanisms linking ATP7B mutations to cholecystitis and natural killer cell exhaustion remain unclear. Specifically, it is not yet determined whether copper metabolism alterations directly cause cholecystitis and natural killer cell exhaustion, or if these effects are secondary to liver dysfunction.</p><p>In this study, we reported for the first time that <italic>ATP7B</italic> mutation and the resulting metabolic abnormalities in hepatocytes cause functional alteration of immune cells in WD patients. We dissected the transcriptional profiles of liver mesenchymal cells and delineated the functional differences of main immune cells in WD patients through scRNA-seq, focusing on the NK cell exhaustion and its clinical significance.</p><p>The mechanism study is of our concern. Given that the <italic>ATP7B</italic> mutation is hepatocyte-specific, its effect on immune cells is most probably through intercellular communication, so we prioritize the studying of this aspect. How <italic>ATP7B</italic> mutation disturbs the metabolic homeostasis in hepatocyte, how metabolic pathways regulate the release of signal substances, and how signal substances act on the NK cells need to be explained. These contents, together with this manuscript, are beyond the scope of a single article, so we put the novelty in this manuscript.</p><p>We sincerely appreciate the comments. The mechanism study is the topic of our follow-up study. We are actively promoting the research and we have found that <italic>ATP7B</italic> mutation rewires a certain metabolism pathway in hepatocyte, and that a critical metabolite functions as the mediator causing NK cell exhaustion.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>Major:</p><p>(1) Abstract. A major portion of this manuscript focuses on non-NK cells. Data that describes NK cell exhaustion is only minimal. Therefore, the authors should modify the abstract.</p></disp-quote><p>Thank you for your valuable suggestion. We have supplemented the description of functional changes in other immune cells, and have modified the abstract (line 31-35).</p><disp-quote content-type="editor-comment"><p>(2) Introduction. There are three paragraphs. The first paragraph discusses cholecystitis. However, there are too many repetitions, and the information is unclear. In the second part, the authors discuss NK cells and their exhaustion. The authors do not establish a clear rationale or logic linking NK cells to WD or cholecystitis. In the last paragraph, the authors describe their findings. Their correlation between NK cell exhaustion and the poor healing process of cholecystitis has no direct experimental proof.</p></disp-quote><p>Thank you for your comments. We have deleted the repetitions and rephrased some sentences (line 72-74). Briefly, in the first paragraph, we proposed the significant prognostic value of immune cell dysfunction for cholecystitis. In the second paragraph, we introduced NK cell exhaustion and its potential to predict prognosis of certain diseases. In the third paragraph, we introduced that the liver is a central organ involved in metabolism and immunity, holding a large number of NK cells. Liver pathologies commonly impact the development and outcome of inflammation-associated diseases such as cholecystitis. WD was selected as a research model. In the last paragraph, we introduced our findings from clinical study, scRNA-seq, clinical samples, and bioinformatics analysis, and concluded at the end.</p><disp-quote content-type="editor-comment"><p>(3) Results. Overall, the results section lacks clarity and a clear focus. Figure legends need to be significantly detailed. The authors make too many broad statements without any support. The authors also make too many overstatements.</p></disp-quote><p>Thank you for your valuable suggestion. We have improved the inaccurate statements and made detailed refinement of figure legends. All the changes are marked in the manuscript, and related responses are described below.</p><disp-quote content-type="editor-comment"><p>Figure 1: No information is provided about the functional impairment of ATP7B protein due to the mutation found in the cohort of Chinese patients. What does 'immune abnormalities' (line 127) mean? What is the relevance of showing liver fibrosis and copper accumulation in the eye in Figure 1c and d, respectively? Total cholesterol concentrations are still within the range in the plasma of WD patients, but the authors call it higher. ECAR has not changed in WD patients, but the authors claim it has (line 117).</p></disp-quote><p>(1) All these gene mutations in WD disable the protein function and cause the same outcome. (2) We have deleted the inappropriate statement. (3) In clinical observation, we found that WD not only causes copper accumulation in hepatocytes, but also leads to a variety of diseases, including liver fibrosis, Kayser-Fleischer Ring, and lower risk of hyperglycemia. We showed these together with the data of cholecystitis incidence. We think these might suggest the significance of intercellular communication between hepatocytes and other cells in microenvironment. (4) We have deleted the inappropriate statement (line 108-110, 112-113).</p><disp-quote content-type="editor-comment"><p>Figure 2: Did the authors use the liver mesenchymal tissue or mesenchymal cells? Figure 2 states that they used mesenchymal cells, different from liver mesenchymal tissue. Numbers within Figure 2b UMAP are not visible. Were the initial T and NK cells annotated as indicated in Figure S2 (CD3D, CD#E, CD3G)? If so, that does not include NK cells.</p></disp-quote><p>(1) The liver mesenchymal cells were used for scRNA-seq. (2) It is possible that the image resolution was reduced due to the compression of files by the submission system during merging process. We confirm that the image resolution of all figures meets publishing requirements, and that all characters on the figures are visible. You can download figure files to view details. (3) It was our negligence that the incomplete cell markers were shown in Figure S2. We have updated the markers (CD3D, CD3E, NKG7), references (Ref #53, #55, and #56), and related figures (Figure 2e, and Figure S2c).</p><disp-quote content-type="editor-comment"><p>Figure 3: The authors should change 'Case' to 'WD patients' both in the text and figures. DEGs in Figure 3C indicate a transcriptomic alteration in the B cell compartment, which the authors do not delineate. Also, the rationale and explanation for the CellChat analyses are minimal. Concluding that a change occurred within the TME with minimal data and explanations is unfair.</p></disp-quote><p>Thank you for your comments. (1) We apologize for the confusion caused by the use of nomenclatures and abbreviations in the text and figures. In all scRNA-seq data analysis, presentation, and description, we used specific terms (CASE and CON) to refer to the group of WD patients and controls, as well as their cell population. We have now unified the use of nomenclature in full text and defined them when first appeared (line 126-127), avoiding using lowercase form to prevent confusion. (2) We have now compared the expression of key genes of B cell between the two group in the next section “The dysfunction of main immune cells in WD patients” (line 230-235, Figure 4e, Figure S4e). (3) We have described the results of cellular communication in more detail (line 188-194). (4) We have modified the conclusion and all the related statement in full text (line 29-31, 82-84, 149, 194-195).</p><disp-quote content-type="editor-comment"><p>Figure 4: This section deals with multiple cell types with minimal explanations. This section discusses various cell types, but it lacks focus. In particular, the T cell section should be separated and elaborated more in detail.</p></disp-quote><p>(1) In this section, we intended to show the comparison in function of main immune cells that account for a considerable proportion, instead of just showing differently expressed genes that provide minimal information. The evaluation of functional signature, based on the integration of multiple gene expression, allows a direct understanding of the final outcome owing to transcriptional changes. (2) Given that the main functions of T cells did not change significantly and there were more significant changes in innate immunity, the T cell section is relatively short and unsuitable as a separated part.</p><disp-quote content-type="editor-comment"><p>Figure 5: What are the distinct subsets of NK cells authors have found in the WD patients and controls? How do these subsets differ between the two groups in numbers and their transcriptomes? The presentation and labeling of Figure 5 and Supplementary Figure 5 need to be vastly improved. The pseudotime presentation in Figure 5b should be presented separately for the patients and the controls. Are the changes in gene expression presented in Figure 5a due to the change in the subset compositions? Figure 5c immuno-staining is not at all visible. A clear explanation should be given for the differences between Figure 5c and Figure 5e, where NKG2A expressions are shown. A better explanation for Figure 5d is required. Did the authors use all the antibodies with the same fluorochrome? If so, what color is that? Can the authors include the individual samples in the bar diagram in Figure 5e? Again, the data in Figure 5 is insufficient to conclude that NK cells are exhausted in WD patients. While the role of changes in the expression of T-BET and EOMES can be related to dysfunction and cellular exhaustion of NK cells, the statement made by the authors needs to be toned down as they do not test with independent experiments.</p></disp-quote><p>(1) The subsets of NK cell were clustered by gene expression profile and labeled by the characteristically expressed gene, using certain algorithm in the routine procedure. They cannot be distinguished in clinical samples by one or several genes or other sorting methods. Thus, we were not able to analyze these subsets in clinical samples. (2) We have supplemented the comparison of numbers and transcriptomes of three NK subtypes between the two groups (line 268-273). (3) We have checked the figures and confirmed that all characters on the figures are visible. (4) We have separately presented the plot in Figure S5d. (5) We compared the expression level of genes presented in Figure 5a between the two groups in three NK subtypes and supplemented this part (line 264-268). The results were very consistent across the three subtypes, suggesting that the results in total NK population were contributed by all three subtypes and not affected by a single composition. (6) KLRC1 is also known as NKG2A. We are sorry for not making a clear explanation, and now we use KLRC1 only in all text to avoid confusion. We have made a more clear and detailed description for Figure 5c, 5d, and 5e (now labeled as Figure 5b, 5c, and 5d), and have included the fluorochrome in Figure 5d (now labeled as Figure 5c) and the individual value in Figure 5e (now labeled as Figure 5d) (line 293-299). (7) In this section, we found the upregulated expression of inhibitory receptors, downregulated expression of effector molecules, and the impaired NK cell-mediated cytotoxicity in NK cell of WD patients from scRNA-seq. Then we validated the findings in clinical liver section samples and clinical blood samples by mIHC and flow cytometry, respectively. According to the recent articles, exhausted NK cells are characterized by decreased production of effector cytokines (e.g., IFNγ), as well as by impaired cytolytic activity, and downregulate expression of certain activating receptors and upregulate expression of inhibitory receptors (e.g., 10.3389/fimmu.2017.00760, 10.1038/s41590-018-0132-0, 10.1038/s41467-019-09212-y, 10.1080/2162402X.2016.1264562). Therefore, we concluded NK cell exhaustion in WD patients. (8) In the part about transcription factors, we kept the description of objective data and deleted the statement of the contribution of transcription factors to NK exhaustion.</p><disp-quote content-type="editor-comment"><p>Figure 6: Data presented in Figure 6 and the conclusion made in this manuscript are predictive. There is no direct testing of ATP7B in NK cells to show the functions of this gene. Extension of this to patient survival is purely speculative. As long as authors state these facts clearly in their text, it can be acceptable. However, they do not extend their conclusions to similar liver diseases.</p></disp-quote><p><italic>ATP7B</italic> mutation is hepatocyte-specific, and it does not occur in any immune cells. The function of ATP7B in NK cell was not studied. We found the NK exhaustion and poor prognosis of cholecystitis in WD patients. Given that there were researches demonstrating that NK exhaustion is correlated with poor liver cancer prognosis, we hypothesized that NK exhaustion contributes to the poor prognosis of cholecystitis. Bioinformatics studies confirmed our hypothesis and supported the extension of this result to other inflammatory diseases. We had no experimental data, but this result was reliable in bioinformatics method.</p><disp-quote content-type="editor-comment"><p>(4) Discussion: While the authors analyzed multiple cell types, the discussion is primarily focused on NK cells. There is no clear link between copper utilization, NK cell function, and exhaustion that the authors articulate.</p></disp-quote><p>Thank you for your comments. The focus of our study is NK cell exhaustion, which is experimentally proven, so we discussed this aspect. We prioritize the effect of intercellular communication and metabolic alteration on the NK cell exhaustion in our follow-up study. Excess copper is released into the circulation in some circumstances in WD patients, but generally they receive long-term de-coppering therapy to maintain intracellular copper at a non-lethal level. Thus, we do not tend to consider copper as a critical factor in this study. In original manuscript, we mentioned the cuproptosis and its potential as a novel target. It is likely to lead to ambiguity and misunderstanding, so we deleted this part to put our point of view clearly.</p><disp-quote content-type="editor-comment"><p>(5) Supplementary Figures: The presentation and labeling of these figures need to be changed.</p></disp-quote><p>Thank you for your suggestions. We have modified the figures and confirmed that all characters on the figures are visible.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>It is better to test whether ATP7B mutation can directly affect immune functions.</p></disp-quote><p>Thank you for your suggestions. Given that the <italic>ATP7B</italic> mutation is hepatocyte-specific, its effect on immune cells is most probably through intercellular communication. Thus, we prioritize the effect of intercellular communication on the NK cell exhaustion and we are actively promoting the research.</p></body></sub-article></article>